context stringlengths 21 33.9k | category stringclasses 2
values | entity stringlengths 1 12 | entity_type stringclasses 5
values | query stringlengths 97 3.31k | answer stringlengths 12 169 |
|---|---|---|---|---|---|
In December of 2024, Boardwalk Pipelines retired at maturity the $ 600 million outstanding aggregate principal amount of its 5.0 % senior notes. | text | 5.0 | percentItemType | text: <entity> 5.0 </entity> <entity type> percentItemType </entity type> <context> In December of 2024, Boardwalk Pipelines retired at maturity the $ 600 million outstanding aggregate principal amount of its 5.0 % senior notes. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
Loews Corporation repurchased 7.7 million, 14.0 million and 12.7 million shares of its common stock at aggregate costs of $ 0.6 billion, $ 0.9 billion and $ 0.7 billion during the years ended December 31, 2024, 2023 and 2022. On December 31, 2024, 7.6 million shares of Loews Corporation common stock were retired. Upon retirement, treasury stock was eliminated through a reduction to common stock, APIC and retained earnings. Loews Corporation purchased | text | 7.7 | sharesItemType | text: <entity> 7.7 </entity> <entity type> sharesItemType </entity type> <context> Loews Corporation repurchased 7.7 million, 14.0 million and 12.7 million shares of its common stock at aggregate costs of $ 0.6 billion, $ 0.9 billion and $ 0.7 billion during the years ended December 31, 2024, 2023 and 2022. On December 31, 2024, 7.6 million shares of Loews Corporation common stock were retired. Upon retirement, treasury stock was eliminated through a reduction to common stock, APIC and retained earnings. Loews Corporation purchased </context> | us-gaap:TreasuryStockSharesAcquired |
Loews Corporation repurchased 7.7 million, 14.0 million and 12.7 million shares of its common stock at aggregate costs of $ 0.6 billion, $ 0.9 billion and $ 0.7 billion during the years ended December 31, 2024, 2023 and 2022. On December 31, 2024, 7.6 million shares of Loews Corporation common stock were retired. Upon retirement, treasury stock was eliminated through a reduction to common stock, APIC and retained earnings. Loews Corporation purchased | text | 14.0 | sharesItemType | text: <entity> 14.0 </entity> <entity type> sharesItemType </entity type> <context> Loews Corporation repurchased 7.7 million, 14.0 million and 12.7 million shares of its common stock at aggregate costs of $ 0.6 billion, $ 0.9 billion and $ 0.7 billion during the years ended December 31, 2024, 2023 and 2022. On December 31, 2024, 7.6 million shares of Loews Corporation common stock were retired. Upon retirement, treasury stock was eliminated through a reduction to common stock, APIC and retained earnings. Loews Corporation purchased </context> | us-gaap:TreasuryStockSharesAcquired |
Loews Corporation repurchased 7.7 million, 14.0 million and 12.7 million shares of its common stock at aggregate costs of $ 0.6 billion, $ 0.9 billion and $ 0.7 billion during the years ended December 31, 2024, 2023 and 2022. On December 31, 2024, 7.6 million shares of Loews Corporation common stock were retired. Upon retirement, treasury stock was eliminated through a reduction to common stock, APIC and retained earnings. Loews Corporation purchased | text | 12.7 | sharesItemType | text: <entity> 12.7 </entity> <entity type> sharesItemType </entity type> <context> Loews Corporation repurchased 7.7 million, 14.0 million and 12.7 million shares of its common stock at aggregate costs of $ 0.6 billion, $ 0.9 billion and $ 0.7 billion during the years ended December 31, 2024, 2023 and 2022. On December 31, 2024, 7.6 million shares of Loews Corporation common stock were retired. Upon retirement, treasury stock was eliminated through a reduction to common stock, APIC and retained earnings. Loews Corporation purchased </context> | us-gaap:TreasuryStockSharesAcquired |
Loews Corporation repurchased 7.7 million, 14.0 million and 12.7 million shares of its common stock at aggregate costs of $ 0.6 billion, $ 0.9 billion and $ 0.7 billion during the years ended December 31, 2024, 2023 and 2022. On December 31, 2024, 7.6 million shares of Loews Corporation common stock were retired. Upon retirement, treasury stock was eliminated through a reduction to common stock, APIC and retained earnings. Loews Corporation purchased | text | 0.6 | monetaryItemType | text: <entity> 0.6 </entity> <entity type> monetaryItemType </entity type> <context> Loews Corporation repurchased 7.7 million, 14.0 million and 12.7 million shares of its common stock at aggregate costs of $ 0.6 billion, $ 0.9 billion and $ 0.7 billion during the years ended December 31, 2024, 2023 and 2022. On December 31, 2024, 7.6 million shares of Loews Corporation common stock were retired. Upon retirement, treasury stock was eliminated through a reduction to common stock, APIC and retained earnings. Loews Corporation purchased </context> | us-gaap:TreasuryStockValueAcquiredCostMethod |
Loews Corporation repurchased 7.7 million, 14.0 million and 12.7 million shares of its common stock at aggregate costs of $ 0.6 billion, $ 0.9 billion and $ 0.7 billion during the years ended December 31, 2024, 2023 and 2022. On December 31, 2024, 7.6 million shares of Loews Corporation common stock were retired. Upon retirement, treasury stock was eliminated through a reduction to common stock, APIC and retained earnings. Loews Corporation purchased | text | 0.9 | monetaryItemType | text: <entity> 0.9 </entity> <entity type> monetaryItemType </entity type> <context> Loews Corporation repurchased 7.7 million, 14.0 million and 12.7 million shares of its common stock at aggregate costs of $ 0.6 billion, $ 0.9 billion and $ 0.7 billion during the years ended December 31, 2024, 2023 and 2022. On December 31, 2024, 7.6 million shares of Loews Corporation common stock were retired. Upon retirement, treasury stock was eliminated through a reduction to common stock, APIC and retained earnings. Loews Corporation purchased </context> | us-gaap:TreasuryStockValueAcquiredCostMethod |
Loews Corporation repurchased 7.7 million, 14.0 million and 12.7 million shares of its common stock at aggregate costs of $ 0.6 billion, $ 0.9 billion and $ 0.7 billion during the years ended December 31, 2024, 2023 and 2022. On December 31, 2024, 7.6 million shares of Loews Corporation common stock were retired. Upon retirement, treasury stock was eliminated through a reduction to common stock, APIC and retained earnings. Loews Corporation purchased | text | 0.7 | monetaryItemType | text: <entity> 0.7 </entity> <entity type> monetaryItemType </entity type> <context> Loews Corporation repurchased 7.7 million, 14.0 million and 12.7 million shares of its common stock at aggregate costs of $ 0.6 billion, $ 0.9 billion and $ 0.7 billion during the years ended December 31, 2024, 2023 and 2022. On December 31, 2024, 7.6 million shares of Loews Corporation common stock were retired. Upon retirement, treasury stock was eliminated through a reduction to common stock, APIC and retained earnings. Loews Corporation purchased </context> | us-gaap:TreasuryStockValueAcquiredCostMethod |
Loews Corporation repurchased 7.7 million, 14.0 million and 12.7 million shares of its common stock at aggregate costs of $ 0.6 billion, $ 0.9 billion and $ 0.7 billion during the years ended December 31, 2024, 2023 and 2022. On December 31, 2024, 7.6 million shares of Loews Corporation common stock were retired. Upon retirement, treasury stock was eliminated through a reduction to common stock, APIC and retained earnings. Loews Corporation purchased | text | 7.6 | sharesItemType | text: <entity> 7.6 </entity> <entity type> sharesItemType </entity type> <context> Loews Corporation repurchased 7.7 million, 14.0 million and 12.7 million shares of its common stock at aggregate costs of $ 0.6 billion, $ 0.9 billion and $ 0.7 billion during the years ended December 31, 2024, 2023 and 2022. On December 31, 2024, 7.6 million shares of Loews Corporation common stock were retired. Upon retirement, treasury stock was eliminated through a reduction to common stock, APIC and retained earnings. Loews Corporation purchased </context> | us-gaap:TreasuryStockSharesRetired |
– As of December 31, 2024 and 2023, receivables from contracts with customers were approximately $ 240 million and $ 228 million and are included within Receivables on the Consolidated Balance Sheets. | text | 240 | monetaryItemType | text: <entity> 240 </entity> <entity type> monetaryItemType </entity type> <context> – As of December 31, 2024 and 2023, receivables from contracts with customers were approximately $ 240 million and $ 228 million and are included within Receivables on the Consolidated Balance Sheets. </context> | us-gaap:ContractWithCustomerAssetNet |
– As of December 31, 2024 and 2023, receivables from contracts with customers were approximately $ 240 million and $ 228 million and are included within Receivables on the Consolidated Balance Sheets. | text | 228 | monetaryItemType | text: <entity> 228 </entity> <entity type> monetaryItemType </entity type> <context> – As of December 31, 2024 and 2023, receivables from contracts with customers were approximately $ 240 million and $ 228 million and are included within Receivables on the Consolidated Balance Sheets. </context> | us-gaap:ContractWithCustomerAssetNet |
– As of December 31, 2024 and 2023, deferred revenue resulting from contracts with customers was approximately $ 4.6 billion and $ 4.8 billion and is reported as Deferred non-insurance warranty revenue and within Other liabilities on the Consolidated Balance Sheets. The decrease in the deferred revenue balance for the year ended December 31, 2024 was primarily driven by recognized revenue from prior periods outpacing new growth in CNA’s non-insurance warranty business. Approximately $ 1.5 billion and | text | 4.6 | monetaryItemType | text: <entity> 4.6 </entity> <entity type> monetaryItemType </entity type> <context> – As of December 31, 2024 and 2023, deferred revenue resulting from contracts with customers was approximately $ 4.6 billion and $ 4.8 billion and is reported as Deferred non-insurance warranty revenue and within Other liabilities on the Consolidated Balance Sheets. The decrease in the deferred revenue balance for the year ended December 31, 2024 was primarily driven by recognized revenue from prior periods outpacing new growth in CNA’s non-insurance warranty business. Approximately $ 1.5 billion and </context> | us-gaap:ContractWithCustomerLiability |
– As of December 31, 2024 and 2023, deferred revenue resulting from contracts with customers was approximately $ 4.6 billion and $ 4.8 billion and is reported as Deferred non-insurance warranty revenue and within Other liabilities on the Consolidated Balance Sheets. The decrease in the deferred revenue balance for the year ended December 31, 2024 was primarily driven by recognized revenue from prior periods outpacing new growth in CNA’s non-insurance warranty business. Approximately $ 1.5 billion and | text | 4.8 | monetaryItemType | text: <entity> 4.8 </entity> <entity type> monetaryItemType </entity type> <context> – As of December 31, 2024 and 2023, deferred revenue resulting from contracts with customers was approximately $ 4.6 billion and $ 4.8 billion and is reported as Deferred non-insurance warranty revenue and within Other liabilities on the Consolidated Balance Sheets. The decrease in the deferred revenue balance for the year ended December 31, 2024 was primarily driven by recognized revenue from prior periods outpacing new growth in CNA’s non-insurance warranty business. Approximately $ 1.5 billion and </context> | us-gaap:ContractWithCustomerLiability |
– As of December 31, 2024 and 2023, deferred revenue resulting from contracts with customers was approximately $ 4.6 billion and $ 4.8 billion and is reported as Deferred non-insurance warranty revenue and within Other liabilities on the Consolidated Balance Sheets. The decrease in the deferred revenue balance for the year ended December 31, 2024 was primarily driven by recognized revenue from prior periods outpacing new growth in CNA’s non-insurance warranty business. Approximately $ 1.5 billion and | text | 1.5 | monetaryItemType | text: <entity> 1.5 </entity> <entity type> monetaryItemType </entity type> <context> – As of December 31, 2024 and 2023, deferred revenue resulting from contracts with customers was approximately $ 4.6 billion and $ 4.8 billion and is reported as Deferred non-insurance warranty revenue and within Other liabilities on the Consolidated Balance Sheets. The decrease in the deferred revenue balance for the year ended December 31, 2024 was primarily driven by recognized revenue from prior periods outpacing new growth in CNA’s non-insurance warranty business. Approximately $ 1.5 billion and </context> | us-gaap:ContractWithCustomerLiabilityRevenueRecognized |
– As of December 31, 2024 and 2023, the Company had approximately $ 3.5 billion and | text | 3.5 | monetaryItemType | text: <entity> 3.5 </entity> <entity type> monetaryItemType </entity type> <context> – As of December 31, 2024 and 2023, the Company had approximately $ 3.5 billion and </context> | us-gaap:CapitalizedContractCostNet |
of costs to obtain contracts with customers related to CNA for amounts paid to dealers and other agents to obtain non-insurance warranty contracts, which are reported as Deferred non-insurance warranty acquisition expenses on the Consolidated Balance Sheets. For the years ended December 31, 2024 and 2023, amortization expense of $ 1.2 billion | text | 1.2 | monetaryItemType | text: <entity> 1.2 </entity> <entity type> monetaryItemType </entity type> <context> of costs to obtain contracts with customers related to CNA for amounts paid to dealers and other agents to obtain non-insurance warranty contracts, which are reported as Deferred non-insurance warranty acquisition expenses on the Consolidated Balance Sheets. For the years ended December 31, 2024 and 2023, amortization expense of $ 1.2 billion </context> | us-gaap:CapitalizedContractCostAmortization |
– As of December 31, 2024, approximately $ 18.6 billion of estimated operating revenues is expected to be recognized in the future related to outstanding performance obligations. The balance relates primarily to revenues for transportation and storage services for natural gas and NGLs and certain ethane supply contracts at Boardwalk Pipelines and non-insurance warranty revenue at CNA. Approximately $ 2.9 billion will be recognized during 2025, $ 2.4 billion in 2026 and the remainder in following years. The actual timing of recognition may vary due to factors outside of the Company’s control. | text | 18.6 | monetaryItemType | text: <entity> 18.6 </entity> <entity type> monetaryItemType </entity type> <context> – As of December 31, 2024, approximately $ 18.6 billion of estimated operating revenues is expected to be recognized in the future related to outstanding performance obligations. The balance relates primarily to revenues for transportation and storage services for natural gas and NGLs and certain ethane supply contracts at Boardwalk Pipelines and non-insurance warranty revenue at CNA. Approximately $ 2.9 billion will be recognized during 2025, $ 2.4 billion in 2026 and the remainder in following years. The actual timing of recognition may vary due to factors outside of the Company’s control. </context> | us-gaap:RevenueRemainingPerformanceObligation |
– As of December 31, 2024, approximately $ 18.6 billion of estimated operating revenues is expected to be recognized in the future related to outstanding performance obligations. The balance relates primarily to revenues for transportation and storage services for natural gas and NGLs and certain ethane supply contracts at Boardwalk Pipelines and non-insurance warranty revenue at CNA. Approximately $ 2.9 billion will be recognized during 2025, $ 2.4 billion in 2026 and the remainder in following years. The actual timing of recognition may vary due to factors outside of the Company’s control. | text | 2.9 | monetaryItemType | text: <entity> 2.9 </entity> <entity type> monetaryItemType </entity type> <context> – As of December 31, 2024, approximately $ 18.6 billion of estimated operating revenues is expected to be recognized in the future related to outstanding performance obligations. The balance relates primarily to revenues for transportation and storage services for natural gas and NGLs and certain ethane supply contracts at Boardwalk Pipelines and non-insurance warranty revenue at CNA. Approximately $ 2.9 billion will be recognized during 2025, $ 2.4 billion in 2026 and the remainder in following years. The actual timing of recognition may vary due to factors outside of the Company’s control. </context> | us-gaap:RevenueRemainingPerformanceObligation |
– As of December 31, 2024, approximately $ 18.6 billion of estimated operating revenues is expected to be recognized in the future related to outstanding performance obligations. The balance relates primarily to revenues for transportation and storage services for natural gas and NGLs and certain ethane supply contracts at Boardwalk Pipelines and non-insurance warranty revenue at CNA. Approximately $ 2.9 billion will be recognized during 2025, $ 2.4 billion in 2026 and the remainder in following years. The actual timing of recognition may vary due to factors outside of the Company’s control. | text | 2.4 | monetaryItemType | text: <entity> 2.4 </entity> <entity type> monetaryItemType </entity type> <context> – As of December 31, 2024, approximately $ 18.6 billion of estimated operating revenues is expected to be recognized in the future related to outstanding performance obligations. The balance relates primarily to revenues for transportation and storage services for natural gas and NGLs and certain ethane supply contracts at Boardwalk Pipelines and non-insurance warranty revenue at CNA. Approximately $ 2.9 billion will be recognized during 2025, $ 2.4 billion in 2026 and the remainder in following years. The actual timing of recognition may vary due to factors outside of the Company’s control. </context> | us-gaap:RevenueRemainingPerformanceObligation |
Dividends from CCC are subject to the insurance holding company laws of the State of Illinois, the domiciliary state of CCC. Under these laws, ordinary dividends, or dividends that do not require prior approval by the Illinois Department of Insurance (the “Department”) are determined based on the greater of the prior year’s statutory net income or 10% of statutory surplus as of the end of the prior year, as well as the timing and amount of dividends paid in the preceding 12 months. Additionally, ordinary dividends may only be paid from earned surplus, which is calculated by removing unrealized gains from unassigned surplus. As of December 31, 2024, CCC was in a positive earned surplus position. The maximum allowable dividend CCC could pay during 2025 that would not be subject to the Department’s prior approval is $ 1.1 billion, less dividends paid during the preceding 12 months measured at that point in time. CCC paid dividends of $ 995 million in | text | 1.1 | monetaryItemType | text: <entity> 1.1 </entity> <entity type> monetaryItemType </entity type> <context> Dividends from CCC are subject to the insurance holding company laws of the State of Illinois, the domiciliary state of CCC. Under these laws, ordinary dividends, or dividends that do not require prior approval by the Illinois Department of Insurance (the “Department”) are determined based on the greater of the prior year’s statutory net income or 10% of statutory surplus as of the end of the prior year, as well as the timing and amount of dividends paid in the preceding 12 months. Additionally, ordinary dividends may only be paid from earned surplus, which is calculated by removing unrealized gains from unassigned surplus. As of December 31, 2024, CCC was in a positive earned surplus position. The maximum allowable dividend CCC could pay during 2025 that would not be subject to the Department’s prior approval is $ 1.1 billion, less dividends paid during the preceding 12 months measured at that point in time. CCC paid dividends of $ 995 million in </context> | us-gaap:StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPayments |
Dividends from CCC are subject to the insurance holding company laws of the State of Illinois, the domiciliary state of CCC. Under these laws, ordinary dividends, or dividends that do not require prior approval by the Illinois Department of Insurance (the “Department”) are determined based on the greater of the prior year’s statutory net income or 10% of statutory surplus as of the end of the prior year, as well as the timing and amount of dividends paid in the preceding 12 months. Additionally, ordinary dividends may only be paid from earned surplus, which is calculated by removing unrealized gains from unassigned surplus. As of December 31, 2024, CCC was in a positive earned surplus position. The maximum allowable dividend CCC could pay during 2025 that would not be subject to the Department’s prior approval is $ 1.1 billion, less dividends paid during the preceding 12 months measured at that point in time. CCC paid dividends of $ 995 million in | text | 995 | monetaryItemType | text: <entity> 995 </entity> <entity type> monetaryItemType </entity type> <context> Dividends from CCC are subject to the insurance holding company laws of the State of Illinois, the domiciliary state of CCC. Under these laws, ordinary dividends, or dividends that do not require prior approval by the Illinois Department of Insurance (the “Department”) are determined based on the greater of the prior year’s statutory net income or 10% of statutory surplus as of the end of the prior year, as well as the timing and amount of dividends paid in the preceding 12 months. Additionally, ordinary dividends may only be paid from earned surplus, which is calculated by removing unrealized gains from unassigned surplus. As of December 31, 2024, CCC was in a positive earned surplus position. The maximum allowable dividend CCC could pay during 2025 that would not be subject to the Department’s prior approval is $ 1.1 billion, less dividends paid during the preceding 12 months measured at that point in time. CCC paid dividends of $ 995 million in </context> | us-gaap:PaymentsOfDividends |
Includes a $ 293 million after-tax loss from pension settlement transactions. Pension settlement transactions are further discussed in Note 16. | text | 293 | monetaryItemType | text: <entity> 293 </entity> <entity type> monetaryItemType </entity type> <context> Includes a $ 293 million after-tax loss from pension settlement transactions. Pension settlement transactions are further discussed in Note 16. </context> | us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1 |
During 2023, the Parent Company completed the termination of a non-contributory defined benefit plan. In total, the plan paid $ 66 million for the purchase of group annuity contracts from a third party insurance company to settle its obligations to retirees and certain participants and $ 34 million in lump sum payments to settle its obligations to certain other participants. The Company recorded a settlement expense of $ 47 million ($ 37 million after-tax) to recognize unrealized losses which were previously included in AOCI. | text | 66 | monetaryItemType | text: <entity> 66 </entity> <entity type> monetaryItemType </entity type> <context> During 2023, the Parent Company completed the termination of a non-contributory defined benefit plan. In total, the plan paid $ 66 million for the purchase of group annuity contracts from a third party insurance company to settle its obligations to retirees and certain participants and $ 34 million in lump sum payments to settle its obligations to certain other participants. The Company recorded a settlement expense of $ 47 million ($ 37 million after-tax) to recognize unrealized losses which were previously included in AOCI. </context> | us-gaap:DefinedBenefitPlanBenefitObligationPaymentForSettlement |
During 2023, the Parent Company completed the termination of a non-contributory defined benefit plan. In total, the plan paid $ 66 million for the purchase of group annuity contracts from a third party insurance company to settle its obligations to retirees and certain participants and $ 34 million in lump sum payments to settle its obligations to certain other participants. The Company recorded a settlement expense of $ 47 million ($ 37 million after-tax) to recognize unrealized losses which were previously included in AOCI. | text | 34 | monetaryItemType | text: <entity> 34 </entity> <entity type> monetaryItemType </entity type> <context> During 2023, the Parent Company completed the termination of a non-contributory defined benefit plan. In total, the plan paid $ 66 million for the purchase of group annuity contracts from a third party insurance company to settle its obligations to retirees and certain participants and $ 34 million in lump sum payments to settle its obligations to certain other participants. The Company recorded a settlement expense of $ 47 million ($ 37 million after-tax) to recognize unrealized losses which were previously included in AOCI. </context> | us-gaap:DefinedBenefitPlanBenefitObligationPaymentForSettlement |
During 2023, the Parent Company completed the termination of a non-contributory defined benefit plan. In total, the plan paid $ 66 million for the purchase of group annuity contracts from a third party insurance company to settle its obligations to retirees and certain participants and $ 34 million in lump sum payments to settle its obligations to certain other participants. The Company recorded a settlement expense of $ 47 million ($ 37 million after-tax) to recognize unrealized losses which were previously included in AOCI. | text | 47 | monetaryItemType | text: <entity> 47 </entity> <entity type> monetaryItemType </entity type> <context> During 2023, the Parent Company completed the termination of a non-contributory defined benefit plan. In total, the plan paid $ 66 million for the purchase of group annuity contracts from a third party insurance company to settle its obligations to retirees and certain participants and $ 34 million in lump sum payments to settle its obligations to certain other participants. The Company recorded a settlement expense of $ 47 million ($ 37 million after-tax) to recognize unrealized losses which were previously included in AOCI. </context> | us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax |
During 2023, the Parent Company completed the termination of a non-contributory defined benefit plan. In total, the plan paid $ 66 million for the purchase of group annuity contracts from a third party insurance company to settle its obligations to retirees and certain participants and $ 34 million in lump sum payments to settle its obligations to certain other participants. The Company recorded a settlement expense of $ 47 million ($ 37 million after-tax) to recognize unrealized losses which were previously included in AOCI. | text | 37 | monetaryItemType | text: <entity> 37 </entity> <entity type> monetaryItemType </entity type> <context> During 2023, the Parent Company completed the termination of a non-contributory defined benefit plan. In total, the plan paid $ 66 million for the purchase of group annuity contracts from a third party insurance company to settle its obligations to retirees and certain participants and $ 34 million in lump sum payments to settle its obligations to certain other participants. The Company recorded a settlement expense of $ 47 million ($ 37 million after-tax) to recognize unrealized losses which were previously included in AOCI. </context> | us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax |
, a subsidiary of CNA, as a sponsor of the CNA Employee Retirement Plan Trust (the “Plan”), paid $ 1 billion to purchase a nonparticipating single premium group annuity contract with Metropolitan Life Insurance Company (the “Insurer”) that transferred to the Insurer $ 1 billion of the Plan’s defined benefit pension obligations. The group annuity contract covers approximately 7,600 Plan participants and beneficiaries (the “Transferred Participants”), representing approximately 60 % of the Plan’s obligations. Under the group annuity contract, the Insurer has made an irrevocable commitment, and will be solely responsible, to pay the pension benefits of each Transferred Participant that are due on and after January 1, 2025. The purchase of the group annuity contract was funded directly by assets of the Plan and required no cash or asset contributions from CNA. As a result of the transaction, CNA recognized a pretax pension settlement charge of | text | 1 | monetaryItemType | text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> , a subsidiary of CNA, as a sponsor of the CNA Employee Retirement Plan Trust (the “Plan”), paid $ 1 billion to purchase a nonparticipating single premium group annuity contract with Metropolitan Life Insurance Company (the “Insurer”) that transferred to the Insurer $ 1 billion of the Plan’s defined benefit pension obligations. The group annuity contract covers approximately 7,600 Plan participants and beneficiaries (the “Transferred Participants”), representing approximately 60 % of the Plan’s obligations. Under the group annuity contract, the Insurer has made an irrevocable commitment, and will be solely responsible, to pay the pension benefits of each Transferred Participant that are due on and after January 1, 2025. The purchase of the group annuity contract was funded directly by assets of the Plan and required no cash or asset contributions from CNA. As a result of the transaction, CNA recognized a pretax pension settlement charge of </context> | us-gaap:DefinedBenefitPlanBenefitObligationPaymentForSettlement |
, a subsidiary of CNA, as a sponsor of the CNA Employee Retirement Plan Trust (the “Plan”), paid $ 1 billion to purchase a nonparticipating single premium group annuity contract with Metropolitan Life Insurance Company (the “Insurer”) that transferred to the Insurer $ 1 billion of the Plan’s defined benefit pension obligations. The group annuity contract covers approximately 7,600 Plan participants and beneficiaries (the “Transferred Participants”), representing approximately 60 % of the Plan’s obligations. Under the group annuity contract, the Insurer has made an irrevocable commitment, and will be solely responsible, to pay the pension benefits of each Transferred Participant that are due on and after January 1, 2025. The purchase of the group annuity contract was funded directly by assets of the Plan and required no cash or asset contributions from CNA. As a result of the transaction, CNA recognized a pretax pension settlement charge of | text | 1 | monetaryItemType | text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> , a subsidiary of CNA, as a sponsor of the CNA Employee Retirement Plan Trust (the “Plan”), paid $ 1 billion to purchase a nonparticipating single premium group annuity contract with Metropolitan Life Insurance Company (the “Insurer”) that transferred to the Insurer $ 1 billion of the Plan’s defined benefit pension obligations. The group annuity contract covers approximately 7,600 Plan participants and beneficiaries (the “Transferred Participants”), representing approximately 60 % of the Plan’s obligations. Under the group annuity contract, the Insurer has made an irrevocable commitment, and will be solely responsible, to pay the pension benefits of each Transferred Participant that are due on and after January 1, 2025. The purchase of the group annuity contract was funded directly by assets of the Plan and required no cash or asset contributions from CNA. As a result of the transaction, CNA recognized a pretax pension settlement charge of </context> | us-gaap:DefinedBenefitPlanSettlementsBenefitObligation |
$ 367 million ($ 265 million after tax and noncontrolling interest). This charge is largely driven by the accelerated recognition of the actuarial pension loss from Accumulated other comprehensive income into Net income, which does not impact Shareholders’ equity. | text | 367 | monetaryItemType | text: <entity> 367 </entity> <entity type> monetaryItemType </entity type> <context> $ 367 million ($ 265 million after tax and noncontrolling interest). This charge is largely driven by the accelerated recognition of the actuarial pension loss from Accumulated other comprehensive income into Net income, which does not impact Shareholders’ equity. </context> | us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1 |
In 2023, the CNA Retirement Plan paid $ 80 million to settle its obligation to certain retirees through the purchase of a group annuity contract from a third party insurance company, which reduced the plan's projected benefit obligation by $ 86 million. | text | 80 | monetaryItemType | text: <entity> 80 </entity> <entity type> monetaryItemType </entity type> <context> In 2023, the CNA Retirement Plan paid $ 80 million to settle its obligation to certain retirees through the purchase of a group annuity contract from a third party insurance company, which reduced the plan's projected benefit obligation by $ 86 million. </context> | us-gaap:DefinedBenefitPlanBenefitObligationPaymentForSettlement |
In 2023, the CNA Retirement Plan paid $ 80 million to settle its obligation to certain retirees through the purchase of a group annuity contract from a third party insurance company, which reduced the plan's projected benefit obligation by $ 86 million. | text | 86 | monetaryItemType | text: <entity> 86 </entity> <entity type> monetaryItemType </entity type> <context> In 2023, the CNA Retirement Plan paid $ 80 million to settle its obligation to certain retirees through the purchase of a group annuity contract from a third party insurance company, which reduced the plan's projected benefit obligation by $ 86 million. </context> | us-gaap:DefinedBenefitPlanBenefitObligationPeriodIncreaseDecrease |
The accumulated benefit obligation for all defined benefit pension plans was $ 854 million and $ 2.0 billion at December 31, 2024 and 2023. Changes for the year ended December 31, 2024 include the impact of the pension settlement transaction discussed above and an actuarial gain of $ 29 million primarily driven by changes in the discount rate used to determine the benefit obligations. | text | 854 | monetaryItemType | text: <entity> 854 </entity> <entity type> monetaryItemType </entity type> <context> The accumulated benefit obligation for all defined benefit pension plans was $ 854 million and $ 2.0 billion at December 31, 2024 and 2023. Changes for the year ended December 31, 2024 include the impact of the pension settlement transaction discussed above and an actuarial gain of $ 29 million primarily driven by changes in the discount rate used to determine the benefit obligations. </context> | us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation |
The accumulated benefit obligation for all defined benefit pension plans was $ 854 million and $ 2.0 billion at December 31, 2024 and 2023. Changes for the year ended December 31, 2024 include the impact of the pension settlement transaction discussed above and an actuarial gain of $ 29 million primarily driven by changes in the discount rate used to determine the benefit obligations. | text | 2.0 | monetaryItemType | text: <entity> 2.0 </entity> <entity type> monetaryItemType </entity type> <context> The accumulated benefit obligation for all defined benefit pension plans was $ 854 million and $ 2.0 billion at December 31, 2024 and 2023. Changes for the year ended December 31, 2024 include the impact of the pension settlement transaction discussed above and an actuarial gain of $ 29 million primarily driven by changes in the discount rate used to determine the benefit obligations. </context> | us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation |
The accumulated benefit obligation for all defined benefit pension plans was $ 854 million and $ 2.0 billion at December 31, 2024 and 2023. Changes for the year ended December 31, 2024 include the impact of the pension settlement transaction discussed above and an actuarial gain of $ 29 million primarily driven by changes in the discount rate used to determine the benefit obligations. | text | 29 | monetaryItemType | text: <entity> 29 </entity> <entity type> monetaryItemType </entity type> <context> The accumulated benefit obligation for all defined benefit pension plans was $ 854 million and $ 2.0 billion at December 31, 2024 and 2023. Changes for the year ended December 31, 2024 include the impact of the pension settlement transaction discussed above and an actuarial gain of $ 29 million primarily driven by changes in the discount rate used to determine the benefit obligations. </context> | us-gaap:DefinedBenefitPlanActuarialGainLoss |
A total return approach is employed whereby a mix of equity, limited partnerships and fixed maturity securities are used to maximize the long-term return of plan assets for a prudent level of risk and to manage cash flows according to plan requirements. The target allocation of plan assets is 0 % to 40 % invested in equity securities and limited partnerships, with the remainder primarily invested in fixed maturity securities. The intent of this strategy is to minimize expenses by generating investment returns that exceed the growth of the plan liabilities over the long run. Risk tolerance is established after careful consideration of the plan liabilities, plan funded status and corporate financial conditions. The investment portfolios contain a diversified blend of fixed maturity, equity and short-term securities. Alternative investments, including limited partnerships, are used to enhance risk adjusted long-term returns while improving portfolio diversification. At December 31, 2024, $ 92 million is committed to fund future capital calls from various third party limited partnership investments in exchange for an ownership interest in the related partnerships. Investment risk is monitored through annual liability measurements, periodic asset/liability studies and quarterly investment portfolio reviews. | text | 0 | percentItemType | text: <entity> 0 </entity> <entity type> percentItemType </entity type> <context> A total return approach is employed whereby a mix of equity, limited partnerships and fixed maturity securities are used to maximize the long-term return of plan assets for a prudent level of risk and to manage cash flows according to plan requirements. The target allocation of plan assets is 0 % to 40 % invested in equity securities and limited partnerships, with the remainder primarily invested in fixed maturity securities. The intent of this strategy is to minimize expenses by generating investment returns that exceed the growth of the plan liabilities over the long run. Risk tolerance is established after careful consideration of the plan liabilities, plan funded status and corporate financial conditions. The investment portfolios contain a diversified blend of fixed maturity, equity and short-term securities. Alternative investments, including limited partnerships, are used to enhance risk adjusted long-term returns while improving portfolio diversification. At December 31, 2024, $ 92 million is committed to fund future capital calls from various third party limited partnership investments in exchange for an ownership interest in the related partnerships. Investment risk is monitored through annual liability measurements, periodic asset/liability studies and quarterly investment portfolio reviews. </context> | us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage |
A total return approach is employed whereby a mix of equity, limited partnerships and fixed maturity securities are used to maximize the long-term return of plan assets for a prudent level of risk and to manage cash flows according to plan requirements. The target allocation of plan assets is 0 % to 40 % invested in equity securities and limited partnerships, with the remainder primarily invested in fixed maturity securities. The intent of this strategy is to minimize expenses by generating investment returns that exceed the growth of the plan liabilities over the long run. Risk tolerance is established after careful consideration of the plan liabilities, plan funded status and corporate financial conditions. The investment portfolios contain a diversified blend of fixed maturity, equity and short-term securities. Alternative investments, including limited partnerships, are used to enhance risk adjusted long-term returns while improving portfolio diversification. At December 31, 2024, $ 92 million is committed to fund future capital calls from various third party limited partnership investments in exchange for an ownership interest in the related partnerships. Investment risk is monitored through annual liability measurements, periodic asset/liability studies and quarterly investment portfolio reviews. | text | 40 | percentItemType | text: <entity> 40 </entity> <entity type> percentItemType </entity type> <context> A total return approach is employed whereby a mix of equity, limited partnerships and fixed maturity securities are used to maximize the long-term return of plan assets for a prudent level of risk and to manage cash flows according to plan requirements. The target allocation of plan assets is 0 % to 40 % invested in equity securities and limited partnerships, with the remainder primarily invested in fixed maturity securities. The intent of this strategy is to minimize expenses by generating investment returns that exceed the growth of the plan liabilities over the long run. Risk tolerance is established after careful consideration of the plan liabilities, plan funded status and corporate financial conditions. The investment portfolios contain a diversified blend of fixed maturity, equity and short-term securities. Alternative investments, including limited partnerships, are used to enhance risk adjusted long-term returns while improving portfolio diversification. At December 31, 2024, $ 92 million is committed to fund future capital calls from various third party limited partnership investments in exchange for an ownership interest in the related partnerships. Investment risk is monitored through annual liability measurements, periodic asset/liability studies and quarterly investment portfolio reviews. </context> | us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage |
In 2025, it is expected that contributions of approximately $ 16 million will be made to pension plans and $ 1 million to postretirement health care and life insurance benefit plans. | text | 16 | monetaryItemType | text: <entity> 16 </entity> <entity type> monetaryItemType </entity type> <context> In 2025, it is expected that contributions of approximately $ 16 million will be made to pension plans and $ 1 million to postretirement health care and life insurance benefit plans. </context> | us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear |
In 2025, it is expected that contributions of approximately $ 16 million will be made to pension plans and $ 1 million to postretirement health care and life insurance benefit plans. | text | 1 | monetaryItemType | text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> In 2025, it is expected that contributions of approximately $ 16 million will be made to pension plans and $ 1 million to postretirement health care and life insurance benefit plans. </context> | us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear |
Stock-based Compensation – In 2016, shareholders approved the Loews Corporation 2016 Incentive Compensation Plan (the “2016 Loews Plan”) which replaced a previously existing equity plan. The aggregate number of shares of Loews Corporation common stock authorized under the 2016 Loews Plan is 6,000,000 shares, plus up to 3,000,000 shares that may be forfeited under the prior plan. The maximum number of shares of Loews Corporation common stock with respect to which awards may be granted to any individual in any calendar year is 500,000 shares. In accordance with the 2016 Loews Plan and the prior equity plan, Loews Corporation stock-based compensation consists of the following: | text | 6000000 | sharesItemType | text: <entity> 6000000 </entity> <entity type> sharesItemType </entity type> <context> Stock-based Compensation – In 2016, shareholders approved the Loews Corporation 2016 Incentive Compensation Plan (the “2016 Loews Plan”) which replaced a previously existing equity plan. The aggregate number of shares of Loews Corporation common stock authorized under the 2016 Loews Plan is 6,000,000 shares, plus up to 3,000,000 shares that may be forfeited under the prior plan. The maximum number of shares of Loews Corporation common stock with respect to which awards may be granted to any individual in any calendar year is 500,000 shares. In accordance with the 2016 Loews Plan and the prior equity plan, Loews Corporation stock-based compensation consists of the following: </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
Stock-based Compensation – In 2016, shareholders approved the Loews Corporation 2016 Incentive Compensation Plan (the “2016 Loews Plan”) which replaced a previously existing equity plan. The aggregate number of shares of Loews Corporation common stock authorized under the 2016 Loews Plan is 6,000,000 shares, plus up to 3,000,000 shares that may be forfeited under the prior plan. The maximum number of shares of Loews Corporation common stock with respect to which awards may be granted to any individual in any calendar year is 500,000 shares. In accordance with the 2016 Loews Plan and the prior equity plan, Loews Corporation stock-based compensation consists of the following: | text | 3000000 | sharesItemType | text: <entity> 3000000 </entity> <entity type> sharesItemType </entity type> <context> Stock-based Compensation – In 2016, shareholders approved the Loews Corporation 2016 Incentive Compensation Plan (the “2016 Loews Plan”) which replaced a previously existing equity plan. The aggregate number of shares of Loews Corporation common stock authorized under the 2016 Loews Plan is 6,000,000 shares, plus up to 3,000,000 shares that may be forfeited under the prior plan. The maximum number of shares of Loews Corporation common stock with respect to which awards may be granted to any individual in any calendar year is 500,000 shares. In accordance with the 2016 Loews Plan and the prior equity plan, Loews Corporation stock-based compensation consists of the following: </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
Stock-based Compensation – In 2016, shareholders approved the Loews Corporation 2016 Incentive Compensation Plan (the “2016 Loews Plan”) which replaced a previously existing equity plan. The aggregate number of shares of Loews Corporation common stock authorized under the 2016 Loews Plan is 6,000,000 shares, plus up to 3,000,000 shares that may be forfeited under the prior plan. The maximum number of shares of Loews Corporation common stock with respect to which awards may be granted to any individual in any calendar year is 500,000 shares. In accordance with the 2016 Loews Plan and the prior equity plan, Loews Corporation stock-based compensation consists of the following: | text | 500000 | sharesItemType | text: <entity> 500000 </entity> <entity type> sharesItemType </entity type> <context> Stock-based Compensation – In 2016, shareholders approved the Loews Corporation 2016 Incentive Compensation Plan (the “2016 Loews Plan”) which replaced a previously existing equity plan. The aggregate number of shares of Loews Corporation common stock authorized under the 2016 Loews Plan is 6,000,000 shares, plus up to 3,000,000 shares that may be forfeited under the prior plan. The maximum number of shares of Loews Corporation common stock with respect to which awards may be granted to any individual in any calendar year is 500,000 shares. In accordance with the 2016 Loews Plan and the prior equity plan, Loews Corporation stock-based compensation consists of the following: </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee |
Time-based restricted stock units (“RSUs”) are granted under the 2016 Loews Plan and represent the right to receive one share of Loews Corporation common stock for each vested RSU. Generally, RSUs vest 50 % on the second anniversary of the grant date and 50 % on the third anniversary of the grant date. | text | 50 | percentItemType | text: <entity> 50 </entity> <entity type> percentItemType </entity type> <context> Time-based restricted stock units (“RSUs”) are granted under the 2016 Loews Plan and represent the right to receive one share of Loews Corporation common stock for each vested RSU. Generally, RSUs vest 50 % on the second anniversary of the grant date and 50 % on the third anniversary of the grant date. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage |
Performance-based RSUs (“PSUs”) are granted under the 2016 Loews Plan and represent the right to receive one share of Loews Corporation common stock for each vested PSU, subject to the achievement of specified performance goals by the Company. Generally, performance-based RSUs vest, if performance goals are satisfied, 50 % on the second anniversary of the grant date and 50 % on the third anniversary of the grant date. | text | 50 | percentItemType | text: <entity> 50 </entity> <entity type> percentItemType </entity type> <context> Performance-based RSUs (“PSUs”) are granted under the 2016 Loews Plan and represent the right to receive one share of Loews Corporation common stock for each vested PSU, subject to the achievement of specified performance goals by the Company. Generally, performance-based RSUs vest, if performance goals are satisfied, 50 % on the second anniversary of the grant date and 50 % on the third anniversary of the grant date. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage |
In 2024, Loews Corporation granted an aggregate of 160,895 RSUs and PSUs at a weighted average grant-date fair value of $ 73.38 per unit. No RSUs were forfeited during the year. 192,000 SARs were outstanding at December 31, 2024 with a weighted average exercise price of $ 38.59 . | text | 160895 | sharesItemType | text: <entity> 160895 </entity> <entity type> sharesItemType </entity type> <context> In 2024, Loews Corporation granted an aggregate of 160,895 RSUs and PSUs at a weighted average grant-date fair value of $ 73.38 per unit. No RSUs were forfeited during the year. 192,000 SARs were outstanding at December 31, 2024 with a weighted average exercise price of $ 38.59 . </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
In 2024, Loews Corporation granted an aggregate of 160,895 RSUs and PSUs at a weighted average grant-date fair value of $ 73.38 per unit. No RSUs were forfeited during the year. 192,000 SARs were outstanding at December 31, 2024 with a weighted average exercise price of $ 38.59 . | text | 73.38 | perShareItemType | text: <entity> 73.38 </entity> <entity type> perShareItemType </entity type> <context> In 2024, Loews Corporation granted an aggregate of 160,895 RSUs and PSUs at a weighted average grant-date fair value of $ 73.38 per unit. No RSUs were forfeited during the year. 192,000 SARs were outstanding at December 31, 2024 with a weighted average exercise price of $ 38.59 . </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
In 2024, Loews Corporation granted an aggregate of 160,895 RSUs and PSUs at a weighted average grant-date fair value of $ 73.38 per unit. No RSUs were forfeited during the year. 192,000 SARs were outstanding at December 31, 2024 with a weighted average exercise price of $ 38.59 . | text | No | sharesItemType | text: <entity> No </entity> <entity type> sharesItemType </entity type> <context> In 2024, Loews Corporation granted an aggregate of 160,895 RSUs and PSUs at a weighted average grant-date fair value of $ 73.38 per unit. No RSUs were forfeited during the year. 192,000 SARs were outstanding at December 31, 2024 with a weighted average exercise price of $ 38.59 . </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod |
In 2024, Loews Corporation granted an aggregate of 160,895 RSUs and PSUs at a weighted average grant-date fair value of $ 73.38 per unit. No RSUs were forfeited during the year. 192,000 SARs were outstanding at December 31, 2024 with a weighted average exercise price of $ 38.59 . | text | 192000 | sharesItemType | text: <entity> 192000 </entity> <entity type> sharesItemType </entity type> <context> In 2024, Loews Corporation granted an aggregate of 160,895 RSUs and PSUs at a weighted average grant-date fair value of $ 73.38 per unit. No RSUs were forfeited during the year. 192,000 SARs were outstanding at December 31, 2024 with a weighted average exercise price of $ 38.59 . </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber |
The Company recognized compensation expense in connection with stock-based compensation that decreased net income by $ 39 million, $ 36 million and $ 34 million for the years ended December 31, 2024, 2023 and 2022. CNA also maintains their own stock-based compensation plan. Such amounts include Loews Corporation’s share of expense related to this plan. | text | 39 | monetaryItemType | text: <entity> 39 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized compensation expense in connection with stock-based compensation that decreased net income by $ 39 million, $ 36 million and $ 34 million for the years ended December 31, 2024, 2023 and 2022. CNA also maintains their own stock-based compensation plan. Such amounts include Loews Corporation’s share of expense related to this plan. </context> | us-gaap:AllocatedShareBasedCompensationExpense |
The Company recognized compensation expense in connection with stock-based compensation that decreased net income by $ 39 million, $ 36 million and $ 34 million for the years ended December 31, 2024, 2023 and 2022. CNA also maintains their own stock-based compensation plan. Such amounts include Loews Corporation’s share of expense related to this plan. | text | 36 | monetaryItemType | text: <entity> 36 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized compensation expense in connection with stock-based compensation that decreased net income by $ 39 million, $ 36 million and $ 34 million for the years ended December 31, 2024, 2023 and 2022. CNA also maintains their own stock-based compensation plan. Such amounts include Loews Corporation’s share of expense related to this plan. </context> | us-gaap:AllocatedShareBasedCompensationExpense |
The Company recognized compensation expense in connection with stock-based compensation that decreased net income by $ 39 million, $ 36 million and $ 34 million for the years ended December 31, 2024, 2023 and 2022. CNA also maintains their own stock-based compensation plan. Such amounts include Loews Corporation’s share of expense related to this plan. | text | 34 | monetaryItemType | text: <entity> 34 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized compensation expense in connection with stock-based compensation that decreased net income by $ 39 million, $ 36 million and $ 34 million for the years ended December 31, 2024, 2023 and 2022. CNA also maintains their own stock-based compensation plan. Such amounts include Loews Corporation’s share of expense related to this plan. </context> | us-gaap:AllocatedShareBasedCompensationExpense |
Insurance claims and policyholders’ benefits reported on the Consolidated Statements of Operations are net of estimated reinsurance recoveries of $ 3.5 billion, $ 2.8 billion and $ 2.6 billion for the years ended December 31, 2024, 2023 and 2022, including $ 1.7 billion, $ 1.5 billion and $ 1.8 billion related to the significant third party captive program discussed above. | text | 3.5 | monetaryItemType | text: <entity> 3.5 </entity> <entity type> monetaryItemType </entity type> <context> Insurance claims and policyholders’ benefits reported on the Consolidated Statements of Operations are net of estimated reinsurance recoveries of $ 3.5 billion, $ 2.8 billion and $ 2.6 billion for the years ended December 31, 2024, 2023 and 2022, including $ 1.7 billion, $ 1.5 billion and $ 1.8 billion related to the significant third party captive program discussed above. </context> | us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded |
Insurance claims and policyholders’ benefits reported on the Consolidated Statements of Operations are net of estimated reinsurance recoveries of $ 3.5 billion, $ 2.8 billion and $ 2.6 billion for the years ended December 31, 2024, 2023 and 2022, including $ 1.7 billion, $ 1.5 billion and $ 1.8 billion related to the significant third party captive program discussed above. | text | 2.8 | monetaryItemType | text: <entity> 2.8 </entity> <entity type> monetaryItemType </entity type> <context> Insurance claims and policyholders’ benefits reported on the Consolidated Statements of Operations are net of estimated reinsurance recoveries of $ 3.5 billion, $ 2.8 billion and $ 2.6 billion for the years ended December 31, 2024, 2023 and 2022, including $ 1.7 billion, $ 1.5 billion and $ 1.8 billion related to the significant third party captive program discussed above. </context> | us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded |
Insurance claims and policyholders’ benefits reported on the Consolidated Statements of Operations are net of estimated reinsurance recoveries of $ 3.5 billion, $ 2.8 billion and $ 2.6 billion for the years ended December 31, 2024, 2023 and 2022, including $ 1.7 billion, $ 1.5 billion and $ 1.8 billion related to the significant third party captive program discussed above. | text | 2.6 | monetaryItemType | text: <entity> 2.6 </entity> <entity type> monetaryItemType </entity type> <context> Insurance claims and policyholders’ benefits reported on the Consolidated Statements of Operations are net of estimated reinsurance recoveries of $ 3.5 billion, $ 2.8 billion and $ 2.6 billion for the years ended December 31, 2024, 2023 and 2022, including $ 1.7 billion, $ 1.5 billion and $ 1.8 billion related to the significant third party captive program discussed above. </context> | us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded |
Insurance claims and policyholders’ benefits reported on the Consolidated Statements of Operations are net of estimated reinsurance recoveries of $ 3.5 billion, $ 2.8 billion and $ 2.6 billion for the years ended December 31, 2024, 2023 and 2022, including $ 1.7 billion, $ 1.5 billion and $ 1.8 billion related to the significant third party captive program discussed above. | text | 1.7 | monetaryItemType | text: <entity> 1.7 </entity> <entity type> monetaryItemType </entity type> <context> Insurance claims and policyholders’ benefits reported on the Consolidated Statements of Operations are net of estimated reinsurance recoveries of $ 3.5 billion, $ 2.8 billion and $ 2.6 billion for the years ended December 31, 2024, 2023 and 2022, including $ 1.7 billion, $ 1.5 billion and $ 1.8 billion related to the significant third party captive program discussed above. </context> | us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded |
Insurance claims and policyholders’ benefits reported on the Consolidated Statements of Operations are net of estimated reinsurance recoveries of $ 3.5 billion, $ 2.8 billion and $ 2.6 billion for the years ended December 31, 2024, 2023 and 2022, including $ 1.7 billion, $ 1.5 billion and $ 1.8 billion related to the significant third party captive program discussed above. | text | 1.5 | monetaryItemType | text: <entity> 1.5 </entity> <entity type> monetaryItemType </entity type> <context> Insurance claims and policyholders’ benefits reported on the Consolidated Statements of Operations are net of estimated reinsurance recoveries of $ 3.5 billion, $ 2.8 billion and $ 2.6 billion for the years ended December 31, 2024, 2023 and 2022, including $ 1.7 billion, $ 1.5 billion and $ 1.8 billion related to the significant third party captive program discussed above. </context> | us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded |
Insurance claims and policyholders’ benefits reported on the Consolidated Statements of Operations are net of estimated reinsurance recoveries of $ 3.5 billion, $ 2.8 billion and $ 2.6 billion for the years ended December 31, 2024, 2023 and 2022, including $ 1.7 billion, $ 1.5 billion and $ 1.8 billion related to the significant third party captive program discussed above. | text | 1.8 | monetaryItemType | text: <entity> 1.8 </entity> <entity type> monetaryItemType </entity type> <context> Insurance claims and policyholders’ benefits reported on the Consolidated Statements of Operations are net of estimated reinsurance recoveries of $ 3.5 billion, $ 2.8 billion and $ 2.6 billion for the years ended December 31, 2024, 2023 and 2022, including $ 1.7 billion, $ 1.5 billion and $ 1.8 billion related to the significant third party captive program discussed above. </context> | us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded |
CNA has provided guarantees, if the primary obligor fails to perform, to holders of structured settlement annuities issued by a previously owned subsidiary. As of December 31, 2024, the potential amount of future payments CNA could be required to pay under these guarantees was approximately $ 1.4 billion, which will be paid over the lifetime of the annuitants. CNA does not believe any payment is likely under these guarantees, as CNA is the beneficiary of a trust that must be maintained at a level that approximates the discounted reserves for these annuities. | text | 1.4 | monetaryItemType | text: <entity> 1.4 </entity> <entity type> monetaryItemType </entity type> <context> CNA has provided guarantees, if the primary obligor fails to perform, to holders of structured settlement annuities issued by a previously owned subsidiary. As of December 31, 2024, the potential amount of future payments CNA could be required to pay under these guarantees was approximately $ 1.4 billion, which will be paid over the lifetime of the annuitants. CNA does not believe any payment is likely under these guarantees, as CNA is the beneficiary of a trust that must be maintained at a level that approximates the discounted reserves for these annuities. </context> | us-gaap:GuaranteeObligationsMaximumExposure |
Loews Corporation has four reportable segments comprised of three individual consolidated operating subsidiaries, CNA, Boardwalk Pipelines and Loews Hotels & Co; and the Corporate segment. The Corporate segment is comprised of Loews Corporation, excluding its consolidated subsidiaries, and includes the equity method of accounting for Altium | text | four | integerItemType | text: <entity> four </entity> <entity type> integerItemType </entity type> <context> Loews Corporation has four reportable segments comprised of three individual consolidated operating subsidiaries, CNA, Boardwalk Pipelines and Loews Hotels & Co; and the Corporate segment. The Corporate segment is comprised of Loews Corporation, excluding its consolidated subsidiaries, and includes the equity method of accounting for Altium </context> | us-gaap:NumberOfReportableSegments |
Pretax net catastrophe losses related to the California wildfires that occurred in January of 2025 are currently estimated between approximately $ 40 million and $ 70 million, and are anticipated to be reflected in the Company’s first quarter 2025 results. | text | 40 | monetaryItemType | text: <entity> 40 </entity> <entity type> monetaryItemType </entity type> <context> Pretax net catastrophe losses related to the California wildfires that occurred in January of 2025 are currently estimated between approximately $ 40 million and $ 70 million, and are anticipated to be reflected in the Company’s first quarter 2025 results. </context> | us-gaap:LossFromCatastrophes |
Pretax net catastrophe losses related to the California wildfires that occurred in January of 2025 are currently estimated between approximately $ 40 million and $ 70 million, and are anticipated to be reflected in the Company’s first quarter 2025 results. | text | 70 | monetaryItemType | text: <entity> 70 </entity> <entity type> monetaryItemType </entity type> <context> Pretax net catastrophe losses related to the California wildfires that occurred in January of 2025 are currently estimated between approximately $ 40 million and $ 70 million, and are anticipated to be reflected in the Company’s first quarter 2025 results. </context> | us-gaap:LossFromCatastrophes |
On November 1, 2023, we acquired (i) all the issued and outstanding shares of Kaplan Electronics, Inc. and (ii) certain assets of Cornell Dubilier Electronics, Inc. and CD Aero, LLC (collectively, "Cornell Dubilier" or "CD") for aggregate consideration of $259.8 million, which equated to a total fair value of consideration transferred of $ 246.8 million. The acquired business is a manufacturer of film, electrolytic, and mica capacitors used in medtech, defense, and industrial electrification applications. The acquisition's operations are included in the PD segment. For additional information, refer to Note 3. Acquisition to our Consolidated Financial Statements under Item 8, "Financial Statements and Supplementary Data." | text | 246.8 | monetaryItemType | text: <entity> 246.8 </entity> <entity type> monetaryItemType </entity type> <context> On November 1, 2023, we acquired (i) all the issued and outstanding shares of Kaplan Electronics, Inc. and (ii) certain assets of Cornell Dubilier Electronics, Inc. and CD Aero, LLC (collectively, "Cornell Dubilier" or "CD") for aggregate consideration of $259.8 million, which equated to a total fair value of consideration transferred of $ 246.8 million. The acquired business is a manufacturer of film, electrolytic, and mica capacitors used in medtech, defense, and industrial electrification applications. The acquisition's operations are included in the PD segment. For additional information, refer to Note 3. Acquisition to our Consolidated Financial Statements under Item 8, "Financial Statements and Supplementary Data." </context> | us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet |
On February 24, 2020, the Company announced that its Board of Directors had authorized a share repurchase program of up to $ 100.0 million of the Company's common stock. On April 28, 2022, we announced that our Board of Directors had increased the authorization by up to $ 150.0 million in additional aggregate value. The timing and amount of any shares repurchased will be determined by the Company based on its evaluation of market conditions and other factors, and will be made in accordance with applicable securities laws in either the open market or in privately negotiated transactions. The Company is not obligated to purchase any shares under the program, and the program may be suspended or discontinued at any time. The actual timing, number, and share price of shares repurchased will depend on a number of factors, including the market price of the Company’s common stock, general market and economic conditions, and applicable legal requirements. Any shares repurchased will be held as treasury stock. During the years ended December 31, 2024, 2023, and 2022, we repurchased 2,987,697 , 2,851,604 , and 2,339,045 shares of common stock, respectively, for a total of $ 53.7 million, $ 47.5 million, and $ 44.0 million, respectively. | text | 2987697 | sharesItemType | text: <entity> 2987697 </entity> <entity type> sharesItemType </entity type> <context> On February 24, 2020, the Company announced that its Board of Directors had authorized a share repurchase program of up to $ 100.0 million of the Company's common stock. On April 28, 2022, we announced that our Board of Directors had increased the authorization by up to $ 150.0 million in additional aggregate value. The timing and amount of any shares repurchased will be determined by the Company based on its evaluation of market conditions and other factors, and will be made in accordance with applicable securities laws in either the open market or in privately negotiated transactions. The Company is not obligated to purchase any shares under the program, and the program may be suspended or discontinued at any time. The actual timing, number, and share price of shares repurchased will depend on a number of factors, including the market price of the Company’s common stock, general market and economic conditions, and applicable legal requirements. Any shares repurchased will be held as treasury stock. During the years ended December 31, 2024, 2023, and 2022, we repurchased 2,987,697 , 2,851,604 , and 2,339,045 shares of common stock, respectively, for a total of $ 53.7 million, $ 47.5 million, and $ 44.0 million, respectively. </context> | us-gaap:StockRepurchasedDuringPeriodShares |
On February 24, 2020, the Company announced that its Board of Directors had authorized a share repurchase program of up to $ 100.0 million of the Company's common stock. On April 28, 2022, we announced that our Board of Directors had increased the authorization by up to $ 150.0 million in additional aggregate value. The timing and amount of any shares repurchased will be determined by the Company based on its evaluation of market conditions and other factors, and will be made in accordance with applicable securities laws in either the open market or in privately negotiated transactions. The Company is not obligated to purchase any shares under the program, and the program may be suspended or discontinued at any time. The actual timing, number, and share price of shares repurchased will depend on a number of factors, including the market price of the Company’s common stock, general market and economic conditions, and applicable legal requirements. Any shares repurchased will be held as treasury stock. During the years ended December 31, 2024, 2023, and 2022, we repurchased 2,987,697 , 2,851,604 , and 2,339,045 shares of common stock, respectively, for a total of $ 53.7 million, $ 47.5 million, and $ 44.0 million, respectively. | text | 2851604 | sharesItemType | text: <entity> 2851604 </entity> <entity type> sharesItemType </entity type> <context> On February 24, 2020, the Company announced that its Board of Directors had authorized a share repurchase program of up to $ 100.0 million of the Company's common stock. On April 28, 2022, we announced that our Board of Directors had increased the authorization by up to $ 150.0 million in additional aggregate value. The timing and amount of any shares repurchased will be determined by the Company based on its evaluation of market conditions and other factors, and will be made in accordance with applicable securities laws in either the open market or in privately negotiated transactions. The Company is not obligated to purchase any shares under the program, and the program may be suspended or discontinued at any time. The actual timing, number, and share price of shares repurchased will depend on a number of factors, including the market price of the Company’s common stock, general market and economic conditions, and applicable legal requirements. Any shares repurchased will be held as treasury stock. During the years ended December 31, 2024, 2023, and 2022, we repurchased 2,987,697 , 2,851,604 , and 2,339,045 shares of common stock, respectively, for a total of $ 53.7 million, $ 47.5 million, and $ 44.0 million, respectively. </context> | us-gaap:StockRepurchasedDuringPeriodShares |
On February 24, 2020, the Company announced that its Board of Directors had authorized a share repurchase program of up to $ 100.0 million of the Company's common stock. On April 28, 2022, we announced that our Board of Directors had increased the authorization by up to $ 150.0 million in additional aggregate value. The timing and amount of any shares repurchased will be determined by the Company based on its evaluation of market conditions and other factors, and will be made in accordance with applicable securities laws in either the open market or in privately negotiated transactions. The Company is not obligated to purchase any shares under the program, and the program may be suspended or discontinued at any time. The actual timing, number, and share price of shares repurchased will depend on a number of factors, including the market price of the Company’s common stock, general market and economic conditions, and applicable legal requirements. Any shares repurchased will be held as treasury stock. During the years ended December 31, 2024, 2023, and 2022, we repurchased 2,987,697 , 2,851,604 , and 2,339,045 shares of common stock, respectively, for a total of $ 53.7 million, $ 47.5 million, and $ 44.0 million, respectively. | text | 2339045 | sharesItemType | text: <entity> 2339045 </entity> <entity type> sharesItemType </entity type> <context> On February 24, 2020, the Company announced that its Board of Directors had authorized a share repurchase program of up to $ 100.0 million of the Company's common stock. On April 28, 2022, we announced that our Board of Directors had increased the authorization by up to $ 150.0 million in additional aggregate value. The timing and amount of any shares repurchased will be determined by the Company based on its evaluation of market conditions and other factors, and will be made in accordance with applicable securities laws in either the open market or in privately negotiated transactions. The Company is not obligated to purchase any shares under the program, and the program may be suspended or discontinued at any time. The actual timing, number, and share price of shares repurchased will depend on a number of factors, including the market price of the Company’s common stock, general market and economic conditions, and applicable legal requirements. Any shares repurchased will be held as treasury stock. During the years ended December 31, 2024, 2023, and 2022, we repurchased 2,987,697 , 2,851,604 , and 2,339,045 shares of common stock, respectively, for a total of $ 53.7 million, $ 47.5 million, and $ 44.0 million, respectively. </context> | us-gaap:StockRepurchasedDuringPeriodShares |
On February 24, 2020, the Company announced that its Board of Directors had authorized a share repurchase program of up to $ 100.0 million of the Company's common stock. On April 28, 2022, we announced that our Board of Directors had increased the authorization by up to $ 150.0 million in additional aggregate value. The timing and amount of any shares repurchased will be determined by the Company based on its evaluation of market conditions and other factors, and will be made in accordance with applicable securities laws in either the open market or in privately negotiated transactions. The Company is not obligated to purchase any shares under the program, and the program may be suspended or discontinued at any time. The actual timing, number, and share price of shares repurchased will depend on a number of factors, including the market price of the Company’s common stock, general market and economic conditions, and applicable legal requirements. Any shares repurchased will be held as treasury stock. During the years ended December 31, 2024, 2023, and 2022, we repurchased 2,987,697 , 2,851,604 , and 2,339,045 shares of common stock, respectively, for a total of $ 53.7 million, $ 47.5 million, and $ 44.0 million, respectively. | text | 53.7 | monetaryItemType | text: <entity> 53.7 </entity> <entity type> monetaryItemType </entity type> <context> On February 24, 2020, the Company announced that its Board of Directors had authorized a share repurchase program of up to $ 100.0 million of the Company's common stock. On April 28, 2022, we announced that our Board of Directors had increased the authorization by up to $ 150.0 million in additional aggregate value. The timing and amount of any shares repurchased will be determined by the Company based on its evaluation of market conditions and other factors, and will be made in accordance with applicable securities laws in either the open market or in privately negotiated transactions. The Company is not obligated to purchase any shares under the program, and the program may be suspended or discontinued at any time. The actual timing, number, and share price of shares repurchased will depend on a number of factors, including the market price of the Company’s common stock, general market and economic conditions, and applicable legal requirements. Any shares repurchased will be held as treasury stock. During the years ended December 31, 2024, 2023, and 2022, we repurchased 2,987,697 , 2,851,604 , and 2,339,045 shares of common stock, respectively, for a total of $ 53.7 million, $ 47.5 million, and $ 44.0 million, respectively. </context> | us-gaap:PaymentsForRepurchaseOfCommonStock |
On February 24, 2020, the Company announced that its Board of Directors had authorized a share repurchase program of up to $ 100.0 million of the Company's common stock. On April 28, 2022, we announced that our Board of Directors had increased the authorization by up to $ 150.0 million in additional aggregate value. The timing and amount of any shares repurchased will be determined by the Company based on its evaluation of market conditions and other factors, and will be made in accordance with applicable securities laws in either the open market or in privately negotiated transactions. The Company is not obligated to purchase any shares under the program, and the program may be suspended or discontinued at any time. The actual timing, number, and share price of shares repurchased will depend on a number of factors, including the market price of the Company’s common stock, general market and economic conditions, and applicable legal requirements. Any shares repurchased will be held as treasury stock. During the years ended December 31, 2024, 2023, and 2022, we repurchased 2,987,697 , 2,851,604 , and 2,339,045 shares of common stock, respectively, for a total of $ 53.7 million, $ 47.5 million, and $ 44.0 million, respectively. | text | 47.5 | monetaryItemType | text: <entity> 47.5 </entity> <entity type> monetaryItemType </entity type> <context> On February 24, 2020, the Company announced that its Board of Directors had authorized a share repurchase program of up to $ 100.0 million of the Company's common stock. On April 28, 2022, we announced that our Board of Directors had increased the authorization by up to $ 150.0 million in additional aggregate value. The timing and amount of any shares repurchased will be determined by the Company based on its evaluation of market conditions and other factors, and will be made in accordance with applicable securities laws in either the open market or in privately negotiated transactions. The Company is not obligated to purchase any shares under the program, and the program may be suspended or discontinued at any time. The actual timing, number, and share price of shares repurchased will depend on a number of factors, including the market price of the Company’s common stock, general market and economic conditions, and applicable legal requirements. Any shares repurchased will be held as treasury stock. During the years ended December 31, 2024, 2023, and 2022, we repurchased 2,987,697 , 2,851,604 , and 2,339,045 shares of common stock, respectively, for a total of $ 53.7 million, $ 47.5 million, and $ 44.0 million, respectively. </context> | us-gaap:PaymentsForRepurchaseOfCommonStock |
On February 24, 2020, the Company announced that its Board of Directors had authorized a share repurchase program of up to $ 100.0 million of the Company's common stock. On April 28, 2022, we announced that our Board of Directors had increased the authorization by up to $ 150.0 million in additional aggregate value. The timing and amount of any shares repurchased will be determined by the Company based on its evaluation of market conditions and other factors, and will be made in accordance with applicable securities laws in either the open market or in privately negotiated transactions. The Company is not obligated to purchase any shares under the program, and the program may be suspended or discontinued at any time. The actual timing, number, and share price of shares repurchased will depend on a number of factors, including the market price of the Company’s common stock, general market and economic conditions, and applicable legal requirements. Any shares repurchased will be held as treasury stock. During the years ended December 31, 2024, 2023, and 2022, we repurchased 2,987,697 , 2,851,604 , and 2,339,045 shares of common stock, respectively, for a total of $ 53.7 million, $ 47.5 million, and $ 44.0 million, respectively. | text | 44.0 | monetaryItemType | text: <entity> 44.0 </entity> <entity type> monetaryItemType </entity type> <context> On February 24, 2020, the Company announced that its Board of Directors had authorized a share repurchase program of up to $ 100.0 million of the Company's common stock. On April 28, 2022, we announced that our Board of Directors had increased the authorization by up to $ 150.0 million in additional aggregate value. The timing and amount of any shares repurchased will be determined by the Company based on its evaluation of market conditions and other factors, and will be made in accordance with applicable securities laws in either the open market or in privately negotiated transactions. The Company is not obligated to purchase any shares under the program, and the program may be suspended or discontinued at any time. The actual timing, number, and share price of shares repurchased will depend on a number of factors, including the market price of the Company’s common stock, general market and economic conditions, and applicable legal requirements. Any shares repurchased will be held as treasury stock. During the years ended December 31, 2024, 2023, and 2022, we repurchased 2,987,697 , 2,851,604 , and 2,339,045 shares of common stock, respectively, for a total of $ 53.7 million, $ 47.5 million, and $ 44.0 million, respectively. </context> | us-gaap:PaymentsForRepurchaseOfCommonStock |
Recoverability of goodwill is measured at the reporting unit level. The Company has three reporting units - Precision Devices ("PD"), Cornell Dubilier ("CD"), and MedTech & Specialty Audio ("MSA"). The goodwill balances associated with PD, CD, and MSA were $ 63.2 million, $ 68.9 million, and $ 137.7 million, respectively, as of December 31, 2024. | text | three | integerItemType | text: <entity> three </entity> <entity type> integerItemType </entity type> <context> Recoverability of goodwill is measured at the reporting unit level. The Company has three reporting units - Precision Devices ("PD"), Cornell Dubilier ("CD"), and MedTech & Specialty Audio ("MSA"). The goodwill balances associated with PD, CD, and MSA were $ 63.2 million, $ 68.9 million, and $ 137.7 million, respectively, as of December 31, 2024. </context> | us-gaap:NumberOfReportingUnits |
Recoverability of goodwill is measured at the reporting unit level. The Company has three reporting units - Precision Devices ("PD"), Cornell Dubilier ("CD"), and MedTech & Specialty Audio ("MSA"). The goodwill balances associated with PD, CD, and MSA were $ 63.2 million, $ 68.9 million, and $ 137.7 million, respectively, as of December 31, 2024. | text | 63.2 | monetaryItemType | text: <entity> 63.2 </entity> <entity type> monetaryItemType </entity type> <context> Recoverability of goodwill is measured at the reporting unit level. The Company has three reporting units - Precision Devices ("PD"), Cornell Dubilier ("CD"), and MedTech & Specialty Audio ("MSA"). The goodwill balances associated with PD, CD, and MSA were $ 63.2 million, $ 68.9 million, and $ 137.7 million, respectively, as of December 31, 2024. </context> | us-gaap:Goodwill |
Recoverability of goodwill is measured at the reporting unit level. The Company has three reporting units - Precision Devices ("PD"), Cornell Dubilier ("CD"), and MedTech & Specialty Audio ("MSA"). The goodwill balances associated with PD, CD, and MSA were $ 63.2 million, $ 68.9 million, and $ 137.7 million, respectively, as of December 31, 2024. | text | 68.9 | monetaryItemType | text: <entity> 68.9 </entity> <entity type> monetaryItemType </entity type> <context> Recoverability of goodwill is measured at the reporting unit level. The Company has three reporting units - Precision Devices ("PD"), Cornell Dubilier ("CD"), and MedTech & Specialty Audio ("MSA"). The goodwill balances associated with PD, CD, and MSA were $ 63.2 million, $ 68.9 million, and $ 137.7 million, respectively, as of December 31, 2024. </context> | us-gaap:Goodwill |
Recoverability of goodwill is measured at the reporting unit level. The Company has three reporting units - Precision Devices ("PD"), Cornell Dubilier ("CD"), and MedTech & Specialty Audio ("MSA"). The goodwill balances associated with PD, CD, and MSA were $ 63.2 million, $ 68.9 million, and $ 137.7 million, respectively, as of December 31, 2024. | text | 137.7 | monetaryItemType | text: <entity> 137.7 </entity> <entity type> monetaryItemType </entity type> <context> Recoverability of goodwill is measured at the reporting unit level. The Company has three reporting units - Precision Devices ("PD"), Cornell Dubilier ("CD"), and MedTech & Specialty Audio ("MSA"). The goodwill balances associated with PD, CD, and MSA were $ 63.2 million, $ 68.9 million, and $ 137.7 million, respectively, as of December 31, 2024. </context> | us-gaap:Goodwill |
- Investments in mutual funds of $ 7.4 million and $ 6.2 million are included in Other assets and deferred charges as of December 31, 2024 and 2023, respectively. These investments are carried at fair value based on quoted prices for identical assets in active markets, resulting in classification within Level 1 of the fair value hierarchy. Gains and losses related to the investments are recorded within the Consolidated Statements of Earnings as a component of Other (income) expense, net. Other assets and deferred charges also include non-current deferred tax assets. | text | 7.4 | monetaryItemType | text: <entity> 7.4 </entity> <entity type> monetaryItemType </entity type> <context> - Investments in mutual funds of $ 7.4 million and $ 6.2 million are included in Other assets and deferred charges as of December 31, 2024 and 2023, respectively. These investments are carried at fair value based on quoted prices for identical assets in active markets, resulting in classification within Level 1 of the fair value hierarchy. Gains and losses related to the investments are recorded within the Consolidated Statements of Earnings as a component of Other (income) expense, net. Other assets and deferred charges also include non-current deferred tax assets. </context> | us-gaap:Investments |
- Investments in mutual funds of $ 7.4 million and $ 6.2 million are included in Other assets and deferred charges as of December 31, 2024 and 2023, respectively. These investments are carried at fair value based on quoted prices for identical assets in active markets, resulting in classification within Level 1 of the fair value hierarchy. Gains and losses related to the investments are recorded within the Consolidated Statements of Earnings as a component of Other (income) expense, net. Other assets and deferred charges also include non-current deferred tax assets. | text | 6.2 | monetaryItemType | text: <entity> 6.2 </entity> <entity type> monetaryItemType </entity type> <context> - Investments in mutual funds of $ 7.4 million and $ 6.2 million are included in Other assets and deferred charges as of December 31, 2024 and 2023, respectively. These investments are carried at fair value based on quoted prices for identical assets in active markets, resulting in classification within Level 1 of the fair value hierarchy. Gains and losses related to the investments are recorded within the Consolidated Statements of Earnings as a component of Other (income) expense, net. Other assets and deferred charges also include non-current deferred tax assets. </context> | us-gaap:Investments |
The terms of a contract or historical business practice can give rise to variable consideration, including customer discounts, rebates, and returns. The Company estimates variable consideration using either the expected value or most likely amount method. We include amounts in the transaction price to the extent it is probable that a significant reversal of revenue will not occur in a subsequent reporting period. Our estimates of variable consideration are based on all reasonably available information (historical, current, and forecasted). Rebates are recognized over the contract period based on expected revenue levels. Sales discounts and rebates totaled $ 4.5 million, $ 3.1 million, and $ 2.7 million for the years ended December 31, 2024, 2023, and 2022, respectively. Returns and allowances totaled $ 4.6 million, $ 3.1 million, and $ 2.1 million for the years ended December 31, 2024, 2023, and 2022, respectively. | text | 4.6 | monetaryItemType | text: <entity> 4.6 </entity> <entity type> monetaryItemType </entity type> <context> The terms of a contract or historical business practice can give rise to variable consideration, including customer discounts, rebates, and returns. The Company estimates variable consideration using either the expected value or most likely amount method. We include amounts in the transaction price to the extent it is probable that a significant reversal of revenue will not occur in a subsequent reporting period. Our estimates of variable consideration are based on all reasonably available information (historical, current, and forecasted). Rebates are recognized over the contract period based on expected revenue levels. Sales discounts and rebates totaled $ 4.5 million, $ 3.1 million, and $ 2.7 million for the years ended December 31, 2024, 2023, and 2022, respectively. Returns and allowances totaled $ 4.6 million, $ 3.1 million, and $ 2.1 million for the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:RevenueRecognitionSalesReturnsReserveForSalesReturns |
The terms of a contract or historical business practice can give rise to variable consideration, including customer discounts, rebates, and returns. The Company estimates variable consideration using either the expected value or most likely amount method. We include amounts in the transaction price to the extent it is probable that a significant reversal of revenue will not occur in a subsequent reporting period. Our estimates of variable consideration are based on all reasonably available information (historical, current, and forecasted). Rebates are recognized over the contract period based on expected revenue levels. Sales discounts and rebates totaled $ 4.5 million, $ 3.1 million, and $ 2.7 million for the years ended December 31, 2024, 2023, and 2022, respectively. Returns and allowances totaled $ 4.6 million, $ 3.1 million, and $ 2.1 million for the years ended December 31, 2024, 2023, and 2022, respectively. | text | 3.1 | monetaryItemType | text: <entity> 3.1 </entity> <entity type> monetaryItemType </entity type> <context> The terms of a contract or historical business practice can give rise to variable consideration, including customer discounts, rebates, and returns. The Company estimates variable consideration using either the expected value or most likely amount method. We include amounts in the transaction price to the extent it is probable that a significant reversal of revenue will not occur in a subsequent reporting period. Our estimates of variable consideration are based on all reasonably available information (historical, current, and forecasted). Rebates are recognized over the contract period based on expected revenue levels. Sales discounts and rebates totaled $ 4.5 million, $ 3.1 million, and $ 2.7 million for the years ended December 31, 2024, 2023, and 2022, respectively. Returns and allowances totaled $ 4.6 million, $ 3.1 million, and $ 2.1 million for the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:RevenueRecognitionSalesReturnsReserveForSalesReturns |
The terms of a contract or historical business practice can give rise to variable consideration, including customer discounts, rebates, and returns. The Company estimates variable consideration using either the expected value or most likely amount method. We include amounts in the transaction price to the extent it is probable that a significant reversal of revenue will not occur in a subsequent reporting period. Our estimates of variable consideration are based on all reasonably available information (historical, current, and forecasted). Rebates are recognized over the contract period based on expected revenue levels. Sales discounts and rebates totaled $ 4.5 million, $ 3.1 million, and $ 2.7 million for the years ended December 31, 2024, 2023, and 2022, respectively. Returns and allowances totaled $ 4.6 million, $ 3.1 million, and $ 2.1 million for the years ended December 31, 2024, 2023, and 2022, respectively. | text | 2.1 | monetaryItemType | text: <entity> 2.1 </entity> <entity type> monetaryItemType </entity type> <context> The terms of a contract or historical business practice can give rise to variable consideration, including customer discounts, rebates, and returns. The Company estimates variable consideration using either the expected value or most likely amount method. We include amounts in the transaction price to the extent it is probable that a significant reversal of revenue will not occur in a subsequent reporting period. Our estimates of variable consideration are based on all reasonably available information (historical, current, and forecasted). Rebates are recognized over the contract period based on expected revenue levels. Sales discounts and rebates totaled $ 4.5 million, $ 3.1 million, and $ 2.7 million for the years ended December 31, 2024, 2023, and 2022, respectively. Returns and allowances totaled $ 4.6 million, $ 3.1 million, and $ 2.1 million for the years ended December 31, 2024, 2023, and 2022, respectively. </context> | us-gaap:RevenueRecognitionSalesReturnsReserveForSalesReturns |
Receivables, net from contracts with customers were $ 89.5 million and $ 86.3 million as of December 31, 2024 and 2023, respectively. See Note 17. Segment Information for disclosures regarding the disaggregation of revenues. | text | 89.5 | monetaryItemType | text: <entity> 89.5 </entity> <entity type> monetaryItemType </entity type> <context> Receivables, net from contracts with customers were $ 89.5 million and $ 86.3 million as of December 31, 2024 and 2023, respectively. See Note 17. Segment Information for disclosures regarding the disaggregation of revenues. </context> | us-gaap:IncreaseDecreaseInContractReceivablesNet |
Receivables, net from contracts with customers were $ 89.5 million and $ 86.3 million as of December 31, 2024 and 2023, respectively. See Note 17. Segment Information for disclosures regarding the disaggregation of revenues. | text | 86.3 | monetaryItemType | text: <entity> 86.3 </entity> <entity type> monetaryItemType </entity type> <context> Receivables, net from contracts with customers were $ 89.5 million and $ 86.3 million as of December 31, 2024 and 2023, respectively. See Note 17. Segment Information for disclosures regarding the disaggregation of revenues. </context> | us-gaap:IncreaseDecreaseInContractReceivablesNet |
- Purchases of property, plant, and equipment included in accounts payable were $ 1.7 million at December 31, 2024, $ 1.1 million at December 31, 2023, and $ 1.1 million at December 31, 2022. These amounts reflect both continuing and discontinued operations. These non-cash amounts are not reflected as Capital expenditures within investing activities of the Consolidated Statements of Cash Flows for the respective periods. | text | 1.7 | monetaryItemType | text: <entity> 1.7 </entity> <entity type> monetaryItemType </entity type> <context> - Purchases of property, plant, and equipment included in accounts payable were $ 1.7 million at December 31, 2024, $ 1.1 million at December 31, 2023, and $ 1.1 million at December 31, 2022. These amounts reflect both continuing and discontinued operations. These non-cash amounts are not reflected as Capital expenditures within investing activities of the Consolidated Statements of Cash Flows for the respective periods. </context> | us-gaap:CapitalExpendituresIncurredButNotYetPaid |
- Purchases of property, plant, and equipment included in accounts payable were $ 1.7 million at December 31, 2024, $ 1.1 million at December 31, 2023, and $ 1.1 million at December 31, 2022. These amounts reflect both continuing and discontinued operations. These non-cash amounts are not reflected as Capital expenditures within investing activities of the Consolidated Statements of Cash Flows for the respective periods. | text | 1.1 | monetaryItemType | text: <entity> 1.1 </entity> <entity type> monetaryItemType </entity type> <context> - Purchases of property, plant, and equipment included in accounts payable were $ 1.7 million at December 31, 2024, $ 1.1 million at December 31, 2023, and $ 1.1 million at December 31, 2022. These amounts reflect both continuing and discontinued operations. These non-cash amounts are not reflected as Capital expenditures within investing activities of the Consolidated Statements of Cash Flows for the respective periods. </context> | us-gaap:CapitalExpendituresIncurredButNotYetPaid |
The Company completed an asset acquisition in 2023 for a total purchase price of approximately $ 2.0 million, including contingent consideration with an estimated fair value at acquisition of $ 1.7 million. This non-cash amount is not reflected in “Acquisition of asset” within Investing Activities on the Consolidated Statement of Cash Flows for the year ended December 31, 2023. | text | 2.0 | monetaryItemType | text: <entity> 2.0 </entity> <entity type> monetaryItemType </entity type> <context> The Company completed an asset acquisition in 2023 for a total purchase price of approximately $ 2.0 million, including contingent consideration with an estimated fair value at acquisition of $ 1.7 million. This non-cash amount is not reflected in “Acquisition of asset” within Investing Activities on the Consolidated Statement of Cash Flows for the year ended December 31, 2023. </context> | us-gaap:FiniteLivedCustomerRelationshipsGross |
The Company completed an asset acquisition in 2023 for a total purchase price of approximately $ 2.0 million, including contingent consideration with an estimated fair value at acquisition of $ 1.7 million. This non-cash amount is not reflected in “Acquisition of asset” within Investing Activities on the Consolidated Statement of Cash Flows for the year ended December 31, 2023. | text | 1.7 | monetaryItemType | text: <entity> 1.7 </entity> <entity type> monetaryItemType </entity type> <context> The Company completed an asset acquisition in 2023 for a total purchase price of approximately $ 2.0 million, including contingent consideration with an estimated fair value at acquisition of $ 1.7 million. This non-cash amount is not reflected in “Acquisition of asset” within Investing Activities on the Consolidated Statement of Cash Flows for the year ended December 31, 2023. </context> | us-gaap:AssetAcquisitionContingentConsiderationLiabilityNoncurrent |
Management and the Board of Directors periodically conduct strategic reviews of the Company’s businesses. On December 27, 2024, the Company completed the sale of the CMM segment to Syntiant Corp. for approximately $ 142.4 million in total consideration, consisting of $ 63.6 million in cash ($ 58.0 million net of cash sold), $ 1.6 million for estimated working capital adjustments, and Series D-2 preferred stock of Syntiant with a fair value $ 77.2 million. The Company will also share in certain separation costs pursuant to a credit for up to $ 13.5 million, which the buyer may apply to specified separation costs post-closing. The Company recorded a gain on the sale of CMM of approximately $ 1.7 million. The gain on sale includes costs to sell of $ 5.1 million and $ 3.4 million for gains reclassified from Accumulated other comprehensive loss. | text | 63.6 | monetaryItemType | text: <entity> 63.6 </entity> <entity type> monetaryItemType </entity type> <context> Management and the Board of Directors periodically conduct strategic reviews of the Company’s businesses. On December 27, 2024, the Company completed the sale of the CMM segment to Syntiant Corp. for approximately $ 142.4 million in total consideration, consisting of $ 63.6 million in cash ($ 58.0 million net of cash sold), $ 1.6 million for estimated working capital adjustments, and Series D-2 preferred stock of Syntiant with a fair value $ 77.2 million. The Company will also share in certain separation costs pursuant to a credit for up to $ 13.5 million, which the buyer may apply to specified separation costs post-closing. The Company recorded a gain on the sale of CMM of approximately $ 1.7 million. The gain on sale includes costs to sell of $ 5.1 million and $ 3.4 million for gains reclassified from Accumulated other comprehensive loss. </context> | us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration |
Management and the Board of Directors periodically conduct strategic reviews of the Company’s businesses. On December 27, 2024, the Company completed the sale of the CMM segment to Syntiant Corp. for approximately $ 142.4 million in total consideration, consisting of $ 63.6 million in cash ($ 58.0 million net of cash sold), $ 1.6 million for estimated working capital adjustments, and Series D-2 preferred stock of Syntiant with a fair value $ 77.2 million. The Company will also share in certain separation costs pursuant to a credit for up to $ 13.5 million, which the buyer may apply to specified separation costs post-closing. The Company recorded a gain on the sale of CMM of approximately $ 1.7 million. The gain on sale includes costs to sell of $ 5.1 million and $ 3.4 million for gains reclassified from Accumulated other comprehensive loss. | text | 58.0 | monetaryItemType | text: <entity> 58.0 </entity> <entity type> monetaryItemType </entity type> <context> Management and the Board of Directors periodically conduct strategic reviews of the Company’s businesses. On December 27, 2024, the Company completed the sale of the CMM segment to Syntiant Corp. for approximately $ 142.4 million in total consideration, consisting of $ 63.6 million in cash ($ 58.0 million net of cash sold), $ 1.6 million for estimated working capital adjustments, and Series D-2 preferred stock of Syntiant with a fair value $ 77.2 million. The Company will also share in certain separation costs pursuant to a credit for up to $ 13.5 million, which the buyer may apply to specified separation costs post-closing. The Company recorded a gain on the sale of CMM of approximately $ 1.7 million. The gain on sale includes costs to sell of $ 5.1 million and $ 3.4 million for gains reclassified from Accumulated other comprehensive loss. </context> | us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets |
Management and the Board of Directors periodically conduct strategic reviews of the Company’s businesses. On December 27, 2024, the Company completed the sale of the CMM segment to Syntiant Corp. for approximately $ 142.4 million in total consideration, consisting of $ 63.6 million in cash ($ 58.0 million net of cash sold), $ 1.6 million for estimated working capital adjustments, and Series D-2 preferred stock of Syntiant with a fair value $ 77.2 million. The Company will also share in certain separation costs pursuant to a credit for up to $ 13.5 million, which the buyer may apply to specified separation costs post-closing. The Company recorded a gain on the sale of CMM of approximately $ 1.7 million. The gain on sale includes costs to sell of $ 5.1 million and $ 3.4 million for gains reclassified from Accumulated other comprehensive loss. | text | 3.4 | monetaryItemType | text: <entity> 3.4 </entity> <entity type> monetaryItemType </entity type> <context> Management and the Board of Directors periodically conduct strategic reviews of the Company’s businesses. On December 27, 2024, the Company completed the sale of the CMM segment to Syntiant Corp. for approximately $ 142.4 million in total consideration, consisting of $ 63.6 million in cash ($ 58.0 million net of cash sold), $ 1.6 million for estimated working capital adjustments, and Series D-2 preferred stock of Syntiant with a fair value $ 77.2 million. The Company will also share in certain separation costs pursuant to a credit for up to $ 13.5 million, which the buyer may apply to specified separation costs post-closing. The Company recorded a gain on the sale of CMM of approximately $ 1.7 million. The gain on sale includes costs to sell of $ 5.1 million and $ 3.4 million for gains reclassified from Accumulated other comprehensive loss. </context> | us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax |
During the year ended December 31, 2024, the Company sold certain technology related to the CMM segment to a third party for total proceeds of $ 7.2 million. After transaction costs of $ 1.8 million, the Company recognized a net gain on the sale of this asset of $ 5.4 million during the year ended December 31, 2024. This gain is reflected as “Gain on sale of asset, net” in the results of discontinued operations above. | text | 7.2 | monetaryItemType | text: <entity> 7.2 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2024, the Company sold certain technology related to the CMM segment to a third party for total proceeds of $ 7.2 million. After transaction costs of $ 1.8 million, the Company recognized a net gain on the sale of this asset of $ 5.4 million during the year ended December 31, 2024. This gain is reflected as “Gain on sale of asset, net” in the results of discontinued operations above. </context> | us-gaap:ProceedsFromSaleOfIntangibleAssets |
During the year ended December 31, 2024, the Company sold certain technology related to the CMM segment to a third party for total proceeds of $ 7.2 million. After transaction costs of $ 1.8 million, the Company recognized a net gain on the sale of this asset of $ 5.4 million during the year ended December 31, 2024. This gain is reflected as “Gain on sale of asset, net” in the results of discontinued operations above. | text | 1.8 | monetaryItemType | text: <entity> 1.8 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2024, the Company sold certain technology related to the CMM segment to a third party for total proceeds of $ 7.2 million. After transaction costs of $ 1.8 million, the Company recognized a net gain on the sale of this asset of $ 5.4 million during the year ended December 31, 2024. This gain is reflected as “Gain on sale of asset, net” in the results of discontinued operations above. </context> | us-gaap:PaymentsForCommissions |
During the year ended December 31, 2023, the Company entered into an agreement to sell certain of its machinery and equipment related to the CMM segment to a third party for total proceeds of $ 11.4 million, which were received in their entirety in 2023. In addition, the Company received $ 1.1 million in 2023, which was initially reserved for a third-party payment. The Company transferred control of a portion of these assets with a fair value of approximately $ 11.2 million to the buyer during the year ended December 31, 2023, resulting in a gain on sale of approximately $ 11.0 million. The remaining assets were transferred to the buyer in 2024 for an immaterial gain. During the year ended December 31, 2024, the Company recorded an additional gain on sale of these assets of approximately $ 1.1 million as a result of changing its estimate on the amount owed to the third party. The Company has now completed this sale transaction. | text | 11.4 | monetaryItemType | text: <entity> 11.4 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2023, the Company entered into an agreement to sell certain of its machinery and equipment related to the CMM segment to a third party for total proceeds of $ 11.4 million, which were received in their entirety in 2023. In addition, the Company received $ 1.1 million in 2023, which was initially reserved for a third-party payment. The Company transferred control of a portion of these assets with a fair value of approximately $ 11.2 million to the buyer during the year ended December 31, 2023, resulting in a gain on sale of approximately $ 11.0 million. The remaining assets were transferred to the buyer in 2024 for an immaterial gain. During the year ended December 31, 2024, the Company recorded an additional gain on sale of these assets of approximately $ 1.1 million as a result of changing its estimate on the amount owed to the third party. The Company has now completed this sale transaction. </context> | us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment |
During the year ended December 31, 2023, the Company entered into an agreement to sell certain of its machinery and equipment related to the CMM segment to a third party for total proceeds of $ 11.4 million, which were received in their entirety in 2023. In addition, the Company received $ 1.1 million in 2023, which was initially reserved for a third-party payment. The Company transferred control of a portion of these assets with a fair value of approximately $ 11.2 million to the buyer during the year ended December 31, 2023, resulting in a gain on sale of approximately $ 11.0 million. The remaining assets were transferred to the buyer in 2024 for an immaterial gain. During the year ended December 31, 2024, the Company recorded an additional gain on sale of these assets of approximately $ 1.1 million as a result of changing its estimate on the amount owed to the third party. The Company has now completed this sale transaction. | text | 1.1 | monetaryItemType | text: <entity> 1.1 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2023, the Company entered into an agreement to sell certain of its machinery and equipment related to the CMM segment to a third party for total proceeds of $ 11.4 million, which were received in their entirety in 2023. In addition, the Company received $ 1.1 million in 2023, which was initially reserved for a third-party payment. The Company transferred control of a portion of these assets with a fair value of approximately $ 11.2 million to the buyer during the year ended December 31, 2023, resulting in a gain on sale of approximately $ 11.0 million. The remaining assets were transferred to the buyer in 2024 for an immaterial gain. During the year ended December 31, 2024, the Company recorded an additional gain on sale of these assets of approximately $ 1.1 million as a result of changing its estimate on the amount owed to the third party. The Company has now completed this sale transaction. </context> | us-gaap:GainLossOnSaleOfPropertyPlantEquipment |
On November 1, 2023, the Company acquired (i) all the issued and outstanding shares of Kaplan Electronics, Inc. and (ii) certain assets of Cornell Dubilier Electronics, Inc. and CD Aero, LLC (collectively, "Cornell Dubilier" or "CD") for aggregate consideration of $ 259.8 million, which equated to a total fair value of consideration transferred of $ 246.8 million. This purchase price of $ 246.8 million consisted of $ 136.9 million in cash payments and an interest-free seller note (the “Seller Note”) with a fair value of $ 109.9 million (see Note 11. Borrowings). | text | 259.8 | monetaryItemType | text: <entity> 259.8 </entity> <entity type> monetaryItemType </entity type> <context> On November 1, 2023, the Company acquired (i) all the issued and outstanding shares of Kaplan Electronics, Inc. and (ii) certain assets of Cornell Dubilier Electronics, Inc. and CD Aero, LLC (collectively, "Cornell Dubilier" or "CD") for aggregate consideration of $ 259.8 million, which equated to a total fair value of consideration transferred of $ 246.8 million. This purchase price of $ 246.8 million consisted of $ 136.9 million in cash payments and an interest-free seller note (the “Seller Note”) with a fair value of $ 109.9 million (see Note 11. Borrowings). </context> | us-gaap:BusinessCombinationConsiderationTransferred1 |
On November 1, 2023, the Company acquired (i) all the issued and outstanding shares of Kaplan Electronics, Inc. and (ii) certain assets of Cornell Dubilier Electronics, Inc. and CD Aero, LLC (collectively, "Cornell Dubilier" or "CD") for aggregate consideration of $ 259.8 million, which equated to a total fair value of consideration transferred of $ 246.8 million. This purchase price of $ 246.8 million consisted of $ 136.9 million in cash payments and an interest-free seller note (the “Seller Note”) with a fair value of $ 109.9 million (see Note 11. Borrowings). | text | 246.8 | monetaryItemType | text: <entity> 246.8 </entity> <entity type> monetaryItemType </entity type> <context> On November 1, 2023, the Company acquired (i) all the issued and outstanding shares of Kaplan Electronics, Inc. and (ii) certain assets of Cornell Dubilier Electronics, Inc. and CD Aero, LLC (collectively, "Cornell Dubilier" or "CD") for aggregate consideration of $ 259.8 million, which equated to a total fair value of consideration transferred of $ 246.8 million. This purchase price of $ 246.8 million consisted of $ 136.9 million in cash payments and an interest-free seller note (the “Seller Note”) with a fair value of $ 109.9 million (see Note 11. Borrowings). </context> | us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet |
On November 1, 2023, the Company acquired (i) all the issued and outstanding shares of Kaplan Electronics, Inc. and (ii) certain assets of Cornell Dubilier Electronics, Inc. and CD Aero, LLC (collectively, "Cornell Dubilier" or "CD") for aggregate consideration of $ 259.8 million, which equated to a total fair value of consideration transferred of $ 246.8 million. This purchase price of $ 246.8 million consisted of $ 136.9 million in cash payments and an interest-free seller note (the “Seller Note”) with a fair value of $ 109.9 million (see Note 11. Borrowings). | text | 136.9 | monetaryItemType | text: <entity> 136.9 </entity> <entity type> monetaryItemType </entity type> <context> On November 1, 2023, the Company acquired (i) all the issued and outstanding shares of Kaplan Electronics, Inc. and (ii) certain assets of Cornell Dubilier Electronics, Inc. and CD Aero, LLC (collectively, "Cornell Dubilier" or "CD") for aggregate consideration of $ 259.8 million, which equated to a total fair value of consideration transferred of $ 246.8 million. This purchase price of $ 246.8 million consisted of $ 136.9 million in cash payments and an interest-free seller note (the “Seller Note”) with a fair value of $ 109.9 million (see Note 11. Borrowings). </context> | us-gaap:PaymentsToAcquireBusinessesGross |
On November 1, 2023, the Company acquired (i) all the issued and outstanding shares of Kaplan Electronics, Inc. and (ii) certain assets of Cornell Dubilier Electronics, Inc. and CD Aero, LLC (collectively, "Cornell Dubilier" or "CD") for aggregate consideration of $ 259.8 million, which equated to a total fair value of consideration transferred of $ 246.8 million. This purchase price of $ 246.8 million consisted of $ 136.9 million in cash payments and an interest-free seller note (the “Seller Note”) with a fair value of $ 109.9 million (see Note 11. Borrowings). | text | 109.9 | monetaryItemType | text: <entity> 109.9 </entity> <entity type> monetaryItemType </entity type> <context> On November 1, 2023, the Company acquired (i) all the issued and outstanding shares of Kaplan Electronics, Inc. and (ii) certain assets of Cornell Dubilier Electronics, Inc. and CD Aero, LLC (collectively, "Cornell Dubilier" or "CD") for aggregate consideration of $ 259.8 million, which equated to a total fair value of consideration transferred of $ 246.8 million. This purchase price of $ 246.8 million consisted of $ 136.9 million in cash payments and an interest-free seller note (the “Seller Note”) with a fair value of $ 109.9 million (see Note 11. Borrowings). </context> | us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred |
The excess of the total purchase price over the total fair value of the identifiable assets and liabilities was recorded as goodwill. The goodwill recognized is primarily attributable to synergies expected to be realized on this transaction and the assembled workforce. Of the total goodwill of $ 69.3 million recognized for this transaction, approximately $ 27.5 million is tax deductible. All goodwill related to CD has been allocated to the PD segment, which is the segment expected to benefit from the acquisition. | text | 69.3 | monetaryItemType | text: <entity> 69.3 </entity> <entity type> monetaryItemType </entity type> <context> The excess of the total purchase price over the total fair value of the identifiable assets and liabilities was recorded as goodwill. The goodwill recognized is primarily attributable to synergies expected to be realized on this transaction and the assembled workforce. Of the total goodwill of $ 69.3 million recognized for this transaction, approximately $ 27.5 million is tax deductible. All goodwill related to CD has been allocated to the PD segment, which is the segment expected to benefit from the acquisition. </context> | us-gaap:Goodwill |
The excess of the total purchase price over the total fair value of the identifiable assets and liabilities was recorded as goodwill. The goodwill recognized is primarily attributable to synergies expected to be realized on this transaction and the assembled workforce. Of the total goodwill of $ 69.3 million recognized for this transaction, approximately $ 27.5 million is tax deductible. All goodwill related to CD has been allocated to the PD segment, which is the segment expected to benefit from the acquisition. | text | 27.5 | monetaryItemType | text: <entity> 27.5 </entity> <entity type> monetaryItemType </entity type> <context> The excess of the total purchase price over the total fair value of the identifiable assets and liabilities was recorded as goodwill. The goodwill recognized is primarily attributable to synergies expected to be realized on this transaction and the assembled workforce. Of the total goodwill of $ 69.3 million recognized for this transaction, approximately $ 27.5 million is tax deductible. All goodwill related to CD has been allocated to the PD segment, which is the segment expected to benefit from the acquisition. </context> | us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount |
Included in the Consolidated Statements of Earnings are CD’s revenues and loss before income taxes of $ 20.2 million and $ 1.1 million, respectively, from the date of acquisition through December 31, 2023. The $ 1.1 million loss before income taxes includes employee retention and intangible asset amortization expense of $ 1.0 million and $ 1.6 million, respectively. | text | 20.2 | monetaryItemType | text: <entity> 20.2 </entity> <entity type> monetaryItemType </entity type> <context> Included in the Consolidated Statements of Earnings are CD’s revenues and loss before income taxes of $ 20.2 million and $ 1.1 million, respectively, from the date of acquisition through December 31, 2023. The $ 1.1 million loss before income taxes includes employee retention and intangible asset amortization expense of $ 1.0 million and $ 1.6 million, respectively. </context> | us-gaap:BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual |
Included in the Consolidated Statements of Earnings are CD’s revenues and loss before income taxes of $ 20.2 million and $ 1.1 million, respectively, from the date of acquisition through December 31, 2023. The $ 1.1 million loss before income taxes includes employee retention and intangible asset amortization expense of $ 1.0 million and $ 1.6 million, respectively. | text | 1.1 | monetaryItemType | text: <entity> 1.1 </entity> <entity type> monetaryItemType </entity type> <context> Included in the Consolidated Statements of Earnings are CD’s revenues and loss before income taxes of $ 20.2 million and $ 1.1 million, respectively, from the date of acquisition through December 31, 2023. The $ 1.1 million loss before income taxes includes employee retention and intangible asset amortization expense of $ 1.0 million and $ 1.6 million, respectively. </context> | us-gaap:BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual |
Included in the Consolidated Statements of Earnings are CD’s revenues and loss before income taxes of $ 20.2 million and $ 1.1 million, respectively, from the date of acquisition through December 31, 2023. The $ 1.1 million loss before income taxes includes employee retention and intangible asset amortization expense of $ 1.0 million and $ 1.6 million, respectively. | text | 1.6 | monetaryItemType | text: <entity> 1.6 </entity> <entity type> monetaryItemType </entity type> <context> Included in the Consolidated Statements of Earnings are CD’s revenues and loss before income taxes of $ 20.2 million and $ 1.1 million, respectively, from the date of acquisition through December 31, 2023. The $ 1.1 million loss before income taxes includes employee retention and intangible asset amortization expense of $ 1.0 million and $ 1.6 million, respectively. </context> | us-gaap:AmortizationOfIntangibleAssets |
The Company recorded measurement period adjustments totaling $ 0.3 million to goodwill during the year ended December 31, 2024 related to the 2023 acquisition of CD. | text | 0.3 | monetaryItemType | text: <entity> 0.3 </entity> <entity type> monetaryItemType </entity type> <context> The Company recorded measurement period adjustments totaling $ 0.3 million to goodwill during the year ended December 31, 2024 related to the 2023 acquisition of CD. </context> | us-gaap:GoodwillPurchaseAccountingAdjustments |
The Company recorded measurement period adjustments totaling $ 0.3 million to customer relationships during the year ended December 31, 2024 related to the 2023 acquisition of CD. | text | 0.3 | monetaryItemType | text: <entity> 0.3 </entity> <entity type> monetaryItemType </entity type> <context> The Company recorded measurement period adjustments totaling $ 0.3 million to customer relationships during the year ended December 31, 2024 related to the 2023 acquisition of CD. </context> | us-gaap:AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions |
Total amortization expense for the years ended December 31, 2024, 2023, and 2022 was $ 17.0 million, $ 7.5 million, and $ 5.8 million, respectively. Amortization expense for the next five years and thereafter, based on current definite-lived intangible balances, is estimated to be as follows: | text | 17.0 | monetaryItemType | text: <entity> 17.0 </entity> <entity type> monetaryItemType </entity type> <context> Total amortization expense for the years ended December 31, 2024, 2023, and 2022 was $ 17.0 million, $ 7.5 million, and $ 5.8 million, respectively. Amortization expense for the next five years and thereafter, based on current definite-lived intangible balances, is estimated to be as follows: </context> | us-gaap:AmortizationOfIntangibleAssets |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.